Using whole genome sequence data to study genomic diversity and develop molecular barcodes to profile Plasmodium malaria parasites by Díez Benavente, E
Dez Benavente, E (2018) Using whole genome sequence data to study
genomic diversity and develop molecular barcodes to profile Plasmod-
ium malaria parasites. PhD (research paper style) thesis, London
School of Hygiene & Tropical Medicine. DOI: https://doi.org/10.17037/PUBS.04650892
Downloaded from: http://researchonline.lshtm.ac.uk/4650892/
DOI: 10.17037/PUBS.04650892
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
 1 
 
 
 
Using whole genome sequence data to study genomic diversity and develop 
molecular barcodes to profile Plasmodium malaria parasites 
 
Ernest Díez Benavente 
 
Thesis submitted in accordance with the requirements for the degree of  
Doctor of Philosophy 
 
University of London  
August 2018 
 
Department of Pathogen Molecular Biology  
Faculty of Infectious and Tropical Diseases 
LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE 
 
 
 
No funding received. 
 
Research group affiliation(s):  Professor Taane G Clark and Associate Professor Susana Campino 
 
 2 
 
 
I, Ernest Diez Benavente, confirm that the work presented in this thesis is my own. Where 
information has been derived from other sources, I confirm that this has been indicated in this 
thesis. 
 
Signed ________________        Date ________________         
  
  
 3 
Abstract 
 
Malaria is a major threat to human health, causing over 300 million clinical cases and 
approximately ~500,000 deaths per year. Countries attempting malaria elimination are 
increasingly concerned with identifying pockets of transmission and outbreaks arising from 
imported cases, and there is a need to establish molecular barcodes for implementation in 
the field. The genetic diversity and non-recombining properties of mitochondrial and 
apicoplast sequence can be powerfully exploited for geographic genetic profiling of P. 
falciparum malaria at an inter-continent level. However, this approach provides limited 
insights for assessing drug resistance, intra-regional geographical differentiation, and ignores 
malaria caused by other Plasmodium spp. (P. vivax and P. knowlesi). To overcome these 
limitations, this project proposes to study the genomic diversity found in the nuclear and 
organellar genomes of the Plasmodium species causing human malaria and establish robust 
ways to create SNP barcodes. In this study, an assessment of the current libraries of genomic 
sequence data across the species P. falciparum, P. vivax and P. knowlesi was performed and 
using a range of bioinformatics approaches the genetic diversity in the different populations 
was assessed.  For this, a new high-quality reference for the A1-H.1 P. knowlesi strain was 
generated and its methylome was characterized. Using this reference, the first evidence of 
genetic exchange events between the three subpopulations of P. knowlesi was found in 
Malaysia. Furthermore, a study of the structural and genetic diversity found in the 
hypervariable vaccine candidate var2csa gene in P. falciparum and its potential geographical 
signal associated with Malaria in Pregnancy (MiP) were performed.  Finally, we accomplished 
a genetic diversity study of global P. vivax isolates and the insights obtained from this analysis 
allowed the development of a 71 SNP barcode to predict the geographical origin of P. vivax 
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isolates. The obtained barcode were tested using prospectively and retrospectively collected 
datasets, particularly from endemic settings with complex mixed infections and near-
elimination settings. The identification of SNP barcodes using this methodology can inform 
future rapid diagnostics and promote the application of field-based sequencing. 
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1. Malaria in the global context 
 
 
The malaria parasites 
Malaria is a protozoan parasitic mosquito-borne disease that can affect humans and 
other animals. The disease is caused by infections with Plasmodium genera parasites. There 
are currently 5 species of Plasmodium that can naturally cause human infections of malaria: 
P. falciparum, P. vivax, P. knowlesi, P. malariae, P. ovale (ssp. curtisi and ssp. wallikeri). 
Infections with P. falciparum and P. vivax, cause the greatest disease burden 1.  
The Plasmodium parasite has a complex life cycle that involves several stages split into 
two differentiated host- and vector-driven larger subdivisions (see Figure 1). The P. falciparum 
host life cycle starts with an infective bite of a female Anopheles mosquito to a human host. 
During the mosquito blood meal, the parasite enters the bloodstream as a sporozoite and 
infects the liver cells where it develops into a schizont, which contains merozoites. The 
merozoites are released into the bloodstream and recognize a range of receptors in the red 
blood cells to invade and develop into a new schizont, which ruptures and starts the 
erythrocytic cycle again. The disease symptoms appear at this blood stage and range from 
fever, tiredness, nausea, and headaches to more severe symptoms such as severe malarial 
anaemia, cerebral malaria, respiratory distress and death. The symptoms usually develop 
between 10 to 15 days after the bite of an infected female mosquito 1. During the erythrocytic 
cycle, some of the parasites develop into the sexual forms, either male or female 
gametocytes. The mosquito takes the gametocytes during a blood meal starting the life cycle 
in the vector. The female and male gametocytes generate an ookinete that matures in the 
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gut into an oocyst full of sporozoites, which migrate into the salivary glands from where it will 
infect the next host when taking the blood meal 2. 
 
Figure 1. Malaria life cycle (https://www.cdc.gov/malaria/about/biology/) 
Burden of disease 
It is estimated that nearly half of the world’s population was at risk of malaria in 2016 
1, with 91 countries considered endemic (Figure 2), 212 million estimated cases and 429,000 
estimated deaths per year. The malaria global burden is unevenly distributed geographically, 
with the sub-Saharan Africa region accounting for the majority of the cases (90%) and deaths 
(92%), with a high mortality burden in children under 5 years of age (70%). Several regions in 
Southeast Asia (SEA), South America and the Middle East are also at high risk 1, with 7% of 
malaria cases occurring in SEA.  
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Figure 2. Malaria-endemic countries in 2000 and 2016. Countries with 3 consecutive years with no cases are considered to 
have eliminated malaria 1.  
Almost all deaths (99%) are caused by P. falciparum parasites, with the remainder due 
to  P. vivax (3,100 deaths; 84% outside Africa) 1. Similarly, P. falciparum causes the vast 
majority of cases worldwide, followed by P. vivax (4% of the total). Nevertheless, excluding 
the African continent, P. vivax is responsible for 41% of the cases 1, which constitutes an 
important challenge for the rest of endemic regions.  
P. knowlesi malaria is a newly emergent zoonotic disease, where the parasite primarily 
infects macaques Macaca fascicularis (Mf, long-tailed) and M. nemestrina (Mn, pig-tailed). 
The geographic distributions of the primary macaque hosts and Anopheles vectors of this 
species are localized in SEA, leading to human populations at risk in that region 3, resulting in 
an increasing number of human cases been reported in Borneo Malaysia since 2004 4.  
The factors driving the geographical distribution of the burden of the disease include 
climatic conditions, such as high temperatures and humidity, which determine the 
distribution of the Anopheles vector together with the host-related factors that either prevent 
or facilitate the transmission of the disease. Human-related disease can be driven by socio-
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economic (e.g. poverty, lack of access to health care) or biological factors (e.g. protective 
genetic characteristics such as sickle cell mutations or the absence of Duffy-binding receptors 
in the red-blood cells) amongst others 5. 
Despite the still high number of cases, malaria incidence has reduced by 40% between 
2000 and 2015 (see Figure 3 for Africa), due mainly to the roll-out of insecticide-treated 
mosquito nets, the use of new antimalarial drugs such as the Artemisinin-combination 
therapies, and the use of indoors residual spraying 1. The target set by the Global Technical 
Strategy for Malaria 2016–2030 is to reduce the mortality and incidence rates by 90% in 2030 
compared to 2015 and eliminate malaria in at least 35 countries 1. One of the main challenges 
to achieve these targets is the presence of antimalarial drug resistance across several 
populations of the different Plasmodium species. Drug resistance occurs when a population 
of parasites, under the pressure of a drug, undergoes rapid selection for variants in their 
genome that confer some advantage in the survival or transmission of the disease in the 
presence of the drug 6. Some of the most commonly used drugs have seen their effectiveness 
challenged by such resistance in two of the main malaria causing species, P. falciparum and 
P. vivax 7. 
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Figure 3. Change in infection prevalence between 2000 and 2015 in the African region (PfPR, Plasmodium falciparum 
prevalence) , figure taken from 8. 
Drug resistance 
P. falciparum is highly resistant to chloroquine in almost all the endemic malaria 
regions spreading from SEA regions in the late 1950s 1. Resistance to sulfadoxine-
pyrimethamine (SP), which was introduced in the early 1940s as an antimalarial, appeared as 
early as 10 years after its introduction and developed in a surprisingly rapid manner leading 
to current widespread SP ineffectiveness 9. In the case of mefloquine, resistance has been 
reported since the mid-1980s in the areas where it has been widely used, mainly in Cambodia, 
Thailand and Vietnam 7. This has pushed the Artemisinin-based Combination Therapies (ACTs) 
to be used as the front-line drug for treatment of P. falciparum malaria. However, artemisinin 
resistance in the form of the slow clearance of parasites has been reported in western 
Cambodia first and has since either spread, emerged independently or both to other regions 
in SEA 10. 
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Regarding P. vivax, drug resistance is not well studied nor understood; resistance to 
chloroquine has been reported in Indonesia and Papua New Guinea as well as closely located 
regions 8. There is also a larger spread of SP resistance in P. vivax 11–16. 
In order to help tackle these challenges, one of the approaches taken by the scientific 
community has been to study and characterize the genome of the Plasmodium parasites 
causing the disease. An approach in which the parasites are isolated from the blood collected 
directly from patients infected with malaria, DNA is extracted and sequenced using high 
throughput sequencing technology, such as the Illumina HiSeq or MiSeq devices 17. 
Understanding the complexity and variability of the Plasmodium genomes can provide 
insights into the biology underlying the disease and inform the processes of drug and vaccine 
development 18, help guide control interventions19 and understand the dynamics and 
mechanisms of drug resistance in the parasites 20. 
Plasmodium genome 
A number of Plasmodium reference genomes have been published: P. falciparum (3D7 
21, in 2002), P. vivax (sal1, 22, 2008), P. knowlesi (H strain, 23, 2008), and P. malariae, P. ovale 
ssp. curtisi and P. ovale ssp wallikeri in 2016 24. These genomes vary in size and GC content 
(see Table 1), and consist of nuclear (>23Mb) and organellar (mitochondria ~6kb, apicoplast 
~35kb) genomes. Whilst nuclear genomes undergo recombination, organellar genomes are 
comparatively highly stable and conserved over time, and are uniparentally co-inherited from 
one of the gametocytes.  
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Table 1. Comparison of the human malaria Plasmodium species 
Plasmodium species Main  
host 
Febrile 
Episodes (h) 
Life cycle peculiarities Genome Genome 
length (Mb) 
GC content 
(%) 
P. falciparum Human ~48 No dormant stage 3D7 21 23.3 19.4 
P. vivax Human  48 Liver dormant stage 
(hypnozoite) causes 
relapses 
Salvador-I 22 26.8 42.3 
P. knowlesi Macaque 
(Macaca spp.) 
24 Zoonotic Disease H Strain 23 23.5 37.5 
P. ovale ssp. curtisi Human  48 Relapse can happen 
up to 4 years after 
infection 
Poc1 (Nigeria 
I) 24 
34.5 28.5 
P. ovale ssp. 
wallikeri 
Human  48 
 
Pow1 
(Gabon) 24 
35.2 28.9 
P. malariae Human 72 
 
Pm (Uganda 
I) 24 
31.9 24.7 
 
Additional “short” sequences or “read” data are being increasingly generated by new 
high throughput sequencing technologies 25, this data characteristically covers the genome 
totally to high depth. As a result large whole genome sequencing data across Plasmodium 
spp. is being placed into the public domain (see Table 2). The study of data sourced from 
endemic field isolates has provided great insight into the structure and distribution of the 
parasite populations and intra- and inter-population genomic diversity 17,26–29. 
However, the use of WGS has been discarded as a ubiquitous solution that can suit all 
the possible scenarios given its high cost and the challenge of obtaining the amount and 
quality of parasite DNA required. Several methods have been used to study and characterize 
the genomic diversity of parasite isolates collected in the field at a lower cost, such as the use 
of microsatellites, a series of tandem repeated sequences which length varies across different 
isolates 30,31.  
Another approach adopted more recently, is to analyze the previously collected WGS data to 
generate single nucleotide polymorphisms (SNP) barcodes that can easily characterize and 
classify geographic subpopulations of Plasmodium isolates within the same species 32,33, 
including the use of robust organellar barcodes 34. 
 19 
Table 2. Available data and prospective data generated 
Plasmodium species Illumina Data 
available 
PacBio long read 
available data 
Illumina Data 
Analyzed in this 
thesis 
PacBio Data 
Analyzed in this 
thesis 
Data being 
generated 
P. falciparum 3407 isolates 21 lines 3407 isolates 21 lines - 
P. vivax 697 isolates - 697 isolates - ~30 isolates 
P. knowlesi 81 isolates 2 lines 81 isolates 2 lines ~20 isolates 
P. ovale ssp. curtisi 4 isolates - 4 isolates - - 
P. ovale ssp. wallikeri 3 isolates - 3 isolates - - 
P. malariae 1 isolate 1 isolate 1 isolate - - 
 
 
2. Plasmodium falciparum 
 
Given the disproportionately high disease burden caused by P. falciparum (Pf), it is the 
most studied species, including from a genetic point of view. The parasite has a genome of 
23.3 Mb in length arranged in 14 chromosomes, 1 mitochondrion genome, present in 
approximately 30 copies per parasite and 2 copies of an apicoplast genome (Table 1) 21. 
The P. falciparum genome has a low GC content (19.4%), which makes the sequencing 
of this parasite a challenge using the available technologies 21. Of special relevance is the var 
gene family, a family of hypervariable genes that are alternatively expressed and presented 
in the surface of the infected Red Blood Cells (RBCs). These proteins help cytoadherence of 
the parasite and have a main role in helping to overcome the host immune system 35. One of 
the genes in this family, the var2csa gene, has been associated with placental malaria and is 
thought to be the responsible for the parasite binding to the receptor chondroitin sulfate A 
in the placenta 36. 
3. Plasmodium vivax 
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Plasmodium vivax is the second most virulent malaria-causing parasite. Its geographic 
distribution includes Asia, Central and South America, the Middle East, Oceania and some 
parts of Africa (e.g. Ethiopia), being more than 2.8 billion people are at risk of infection 2. 
Given its low mortality rates and the current inability to culture the parasite in vitro, it is 
considered a neglected tropical disease compared to P. falciparum 1. 
Some of the control interventions aimed at reducing P. falciparum incidence rates are 
not as effective when applied to P. vivax given its very particular biology, including the 
hypnozoite, a dormant stage that can persist for a long time in the human liver 37 (Table 1). 
This stage of the parasite can then relapse after a period of time that ranges from several 
months to years in some cases 38. Thus, P. vivax has become the most prevalent malaria 
parasite in some of the countries where P. falciparum control measures have been rolled out 
and its presence and transmission has been effectively reduced 39,40. Control and future 
elimination of the P. vivax malaria requires additional efforts to effectively combat the 
dormant liver stage. Genomic research is an approach with the potential to contribute greatly 
to our understanding of the basic biology and evolution trends of P. vivax; thus, supporting 
the future interventions during development and surveillance stages.  
The sequencing and characterization of the P. vivax genome (Sal-1 22) primed 
population genetic studies, the first of them based on microsatellite data 41–43. The 
development of appropriate DNA isolation and amplification of clinical samples involving high 
parasitaemias has led to whole genome sequencing. These studies have shed light into the 
high degree of polymorphism of this parasite compared to P. falciparum 27,28,44,45. Even on a 
small spatial scale, P. vivax populations present high genomic diversity, this variability may be 
due to host genomics, vector species and environmental factors 28,44,45.  
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The advances in WGS technologies and ability to multiplex many samples has opened up 
the opportunity to obtain a data-driven picture of the genomic epidemiology and genetic 
diversity of P. vivax populations. This includes identifying structural variation that define P. 
vivax populations, which can assist the development of appropriate geographical barcodes 
for this species, as previously implemented for P. falciparum 33,46. 
4. Plasmodium knowlesi 
 
This parasite species is now recognized as a substantial cause of malaria in humans, and 
infections are now known to be widespread across SEA 47 including cases of travellers from 
outside the region 48. The clinical symptoms of disease range from asymptomatic carriage to 
high levels of parasitaemia, which in severe cases, can lead to death 49,50. The deforestation 
and encroachment on the wild macaque habitats as a consequence of human population 
growth can increase the chances of human-macaque contact 51. 
The analysis of WGS data from P. knowlesi isolates from human infections in Sarikei in 
Malaysia Borneo demonstrated existing dimorphism over at least 50% of the P. knowlesi 
genome 52. Microsatellite diversity in parasites from both macaque and human infections 
across Borneo and Peninsular Malaysia supported this observation, and found a strong 
association of the two distinct genome dimorphs with adaptations to either of the two 
Macaca host, but with no evidence of a complete primate host susceptibility barrier 53. Most 
recently, a new geographical genetic cluster has been identified from Peninsular Malaysia 
29,54–56.  Genomic diversity in P. knowlesi is likely to be driven by host- and geography-related 
factors, as well as the contemporary effect of the human alteration in host and vector 
distributions during the ecological transition that is taking place in the region 57.  
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Several Anopheles species from the Leuchosphyrus group are able to transmit P. 
knowlesi malaria. Some examples are A. latens and A. balbacensis in Borneo, Malaysia 58–60, 
A. cracens and A. hackeri in the Peninsula in Malaysia 61 and A. dirus in Vietnam 62.  
It is required to undertake in-depth studies that help elucidate the impact of such 
diverse host and vector patterns in the evolution of the P. knowlesi genome. These studies 
will help understand how the different geographic and host-related subpopulations of this 
parasite are structured. Such knowledge would be crucial in order to design suitable SNP 
barcodes for this highly variable species. 
Furthermore, there is a need to further investigate the structure and characteristics of 
complex gene families such as the SICAvar genes, which are expressed in the surface of the 
infected RBCs and are responsible for the antigenic variation and immune evasion in the host, 
a highly similar function is carried out by the var genes in the P. falciparum parasites.   
5. Other Plasmodium species 
 
There are two other main species causing human malaria, P. ovale and P. malariae. These 
species have been less studied given their low prevalence and mild disease symptoms, 
although there have been reports of rare severe cases 63. The two subspecies of P. ovale are 
morphologically indistinguishable, but analysis of their genomic sequences revealed a 
dimorphism between the two 64. They show a sympatric distribution throughout the tropics 
in Africa, Asia and Oceania although its prevalence is thought to be highly underestimated 63. 
This species shares with P. vivax the capability to form hypnozoites, a dormant liver stage that 
can relapse up to 3 years after infection 65. 
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P. malariae is a Plasmodium causing quartian human malaria and is associated with the 
production of immune complexes located in the patient kidneys, which can develop into a 
nephrotic syndrome 66. 
The use of WGS to study these parasites is still embryonic, but the sequencing of the genomes 
for these two species 24 has opened up the opportunity to inform the biology of their 
populations. Their genomes have shown the presence of expanded pir and surfin gene 
families, which increases the length of their genomes up to a size of ~35 Mb 24. The most 
recent sequencing study considering co-infections of these parasites with other Plasmodium 
species, sheds light on the evolutionary relationships of species within the Plasmodium 
lineage, estimating the divergence of the 2 P. ovale subspecies at 20.3 million years ago 67. 
These species are normally found in mixed infections together with other Plasmodium species 
and therefore it is of great interest to identify highly sensitive genetic markers to detect the 
presence of these parasites, and therefore their actual prevalence in prospective studies. 
6. The need for a barcode of Plasmodium and attempts to date 
 
The use of SNP barcodes for Plasmodium parasites has been made possible by advances 
in whole genome sequencing. The first attempt in P. falciparum used 24 nuclear SNPs to 
identify and track the isolates of a population 46. The underlying SNPS within this barcode 
were derived from the genome sequences of long-term adapted laboratory lines 46. The 24-
SNP barcode was then applied in an endemic region in Senegal, analysing samples over a 7-
year period 68 to infer transmission intensity. This work demonstrated the potential that 
genomic barcodes in combination with epidemiological methods have to elucidate 
transmission intensity 68. Nevertheless, the use of isolates from a very limited region to 
generate the initial barcode, can potentially underestimate the genomic variability present in 
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the overall population. A recent study showed that the prediction power of the 24 SNP 
barcode for geographical determination was poor compared to one formed of 23 SNPs in the 
mitochondria and apicoplast organellar genomes, which predicted the continental origin of 
samples with 92% accuracy 33.  
A recently published barcode formed of 105 highly frequent SNPs was developed to 
estimate the complexity of infection of samples and therefore, like the 24 SNP barcode, infer 
transmission intensity 69. However, the markers were selected using a much broader panel of 
data, thereby proving greater utility across malaria-endemic countries 69.   
These studies demonstrated how barcodes can potentially provide insight into the 
intensity of transmission, identify the geographical origin of the field isolates, and inform 
dynamics of the diversity in a parasite population. They could also identify potential imported 
outbreaks as well as mixed infections involving Plasmodium spp. Other efforts have 
attempted to generate similar barcodes for species such as P. vivax 32,70 but they were also 
based on limited datasets, and therefore can have poor predictive power when used for more 
geographically distinct datasets. 
The current diagnostic for the different Plasmodium sp. relies on microscopy, which 
although cheap and easy to implement, is prone to misdiagnosis. A routine PCR approach 
used in reference laboratories, which is based on the amplification of the small subunit 
ribosomal RNA (ssrRNA), can identify the presence/non-presence of the Plasmodium species 
72. However, the creation of SNP-based barcodes could potentially make this identification 
cheaper and more informative.  
As technology advances, the implementation of high throughput sequencing of specific 
regions of the genome for high number of samples is becoming cheaper and more rapid to 
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implement, by using pooled PCR assays which can be multiplexed in the Illumina sequencing 
machine using sequence barcodes for each sample 73. The identification of informative 
regions in the Plasmodium genomes gains relevance under this scenario. Therefore, in 
combination with the use of new technologies such as the Oxford Nanopore MiniOn, could 
potentially make the use of barcodes to predict origin as well as infer transmission patterns  
possible in real time 74. 
Data available 
In my work, I sought to understand the genetic diversity across Plasmodium species and 
construct intra-species and regional molecular barcodes that could be implemented in the 
field. The majority of data available (Table 2) has come from Illumina sequencing 
technologies, including MiSeq or the HiSeq platforms 75. I use raw sequence data that has 
been previously published and publicly available 17,27–29,52, and is complemented by in-house 
data generated through our collaborations. 
To tackle these questions, in Chapter 2 I generated a new high-quality reference for the A1-
H.1 P. knowlesi strain and studied epigenetic methylation patterns. Using this new reference, 
in Chapters 3 and 4 we provided evidence for the first time of both recent and non-recent 
genetic introgression events occurring between the three subpopulations of P. knowlesi 
found in both Borneo and Peninsular Malaysia. In Chapter 5, I attempted to use the 
sequencing diversity found in the hypervariable vaccine candidate var2csa gene in P. 
falciparum in order to identify geography specific signatures, while performing a structural 
and genetic diversity analysis of the gene. Finally, in Chapters 6 and 7 I performed a genetic 
diversity study of global P. vivax isolates from both South East Asia and South America where 
prevalence of P. vivax is high, I then used the insights obtained from the analysis and 
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complementary isolate data to develop a 71 SNP barcode to predict the geographical origin 
of P. vivax isolates. This barcode was assessed using prospectively and retrospectively 
collected datasets, particularly from endemic settings with complex mixed infections and 
near-elimination settings in Chapter 7. 
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Total PkA1-H.1
PkA1-H.1 
Fraction 
genome
PkA1-H.1
PKNH 
Mapped
PKNH 
Fraction 
genome
PKNH 
Coverage
Reads Mapped covered Coverage Reads (%) covered Mean
Reads (%) Mean
ERR274221 46353062 96.9 0.99 174.1 97.0 0.96 175.5
ERR274222 60189967 97.7 0.99 228.7 97.8 0.96 230.7
ERR274224 42350437 97.0 0.98 161.5 97.0 0.95 162.8
ERR274225 52883838 97.2 0.98 201.6 97.2 0.95 203.2
ERR366425 6391836 97.1 0.95 36.0 97.2 0.92 36.3
ERR366426 6270503 94.8 0.95 34.1 94.8 0.92 34.3
ERR985372 30620879 66.0 0.98 79.7 66.0 0.95 80.3
ERR985374 55120863 96.4 0.99 207.5 80.5 0.95 102.6
ERR985375 66747737 22.7 0.98 55.4 96.5 0.96 209.2
ERR985376 50924729 79.3 0.99 157.7 22.7 0.95 55.8
ERR985377 71277238 95.3 0.99 248.7 79.4 0.96 159.1
ERR985378 47365570 95.6 0.99 177.7 95.4 0.96 250.7
ERR985379 40897898 95.5 0.99 153.6 95.7 0.96 179.1
ERR985380 61989913 97.2 1.00 234.8 95.6 0.96 154.8
ERR985381 51234398 94.9 0.99 189.9 97.3 0.97 236.8
ERR985382 48838502 49.6 0.98 89.3 94.9 0.96 191.5
ERR985383 40307405 85.8 0.99 126.8 49.6 0.95 90.0
ERR985384 52753853 88.0 0.99 167.0 85.8 0.96 127.7
ERR985385 93728041 60.6 1.00 213.1 88.0 0.96 171.4
ERR985386 52908664 22.3 0.98 45.3 60.6 0.97 214.9
ERR985387 48092075 91.8 0.99 173.0 22.3 0.95 45.6
ERR985388 68600487 92.2 0.99 247.4 91.8 0.96 174.4
ERR985394 26219163 95.2 0.98 99.0 92.3 0.96 249.4
ERR985395 45997535 86.1 1.00 154.6 88.6 0.95 108.1
ERR985396 31849384 60.9 0.99 76.4 85.7 0.95 101.0
ERR985397 40463921 92.0 1.00 146.3 91.5 0.95 121.6
ERR985398 33387794 61.2 0.98 80.5 88.4 0.95 115.4
ERR985399 34420982 97.0 0.99 131.2 73.2 0.95 75.4
ERR985400 36366112 84.6 0.99 121.4 95.3 0.95 99.8
ERR985401 36045889 95.3 0.99 135.9 86.1 0.97 155.9
ERR985402 56171218 92.5 0.99 202.0 60.9 0.96 76.9
ERR985403 52517284 95.4 0.99 193.6 92.1 0.96 147.5
ERR985404 52157592 94.6 1.00 190.2 61.3 0.95 81.1
ERR985410 32160549 97.1 0.99 122.9 97.0 0.96 132.2
ERR985411 54179835 80.4 0.98 161.6 84.6 0.95 122.3
ERR985412 66023442 44.2 0.99 109.4 95.4 0.95 137.0
ERR985414 65300398 93.9 0.99 242.3 92.6 0.96 203.6
ERR985415 60931327 92.5 0.99 223.7 95.4 0.96 195.2
ERR985416 78064720 92.6 0.99 286.4 94.7 0.96 191.7
ERR985417 41500510 95.7 0.99 157.1 89.9 0.96 109.1
ERR985418 54311715 89.9 0.98 191.6 85.3 0.95 119.8
ERR985419 57630655 81.2 0.99 183.6 87.7 0.95 115.2
ERR985373 42713162 78.6 0.98 119.3 88.5 0.95 127.1
ERR985389 41469453 86.3 0.99 126.4 82.9 0.96 115.8
ERR985390 41673914 83.2 0.99 117.2 97.1 0.96 123.9
ERR985391 40562077 90.6 0.99 141.0 80.4 0.95 162.9
ERR985392 42267002 87.0 0.99 132.1 44.2 0.96 110.2
ERR985393 34929904 71.1 0.98 88.5 77.7 0.95 102.9
ERR985405 38834680 88.7 1.00 128.1 93.9 0.95 244.2
ERR985406 47157966 83.6 0.99 138.9 92.5 0.96 225.6
ERR985407 43617554 86.2 0.99 135.2 92.7 0.96 289.0
ERR985408 47394270 86.8 0.99 148.1 95.8 0.96 158.4
ERR985409 50949905 80.5 0.99 134.1 89.9 0.95 193.1
ERR985413 51040091 74.5 0.98 119.8 81.3 0.96 185.0
SRR2221468 22542689 94.5 0.99 83.2 94.6 0.96 83.8
SRR2222335 23371486 96.1 1.00 89.6 96.2 0.99 90.0
SRR2225467 19455031 79.3 1.00 60.9 79.4 0.99 61.4
SRR2225571 22264926 74.6 0.98 64.0 74.6 0.95 64.5
SRR2225573 25538996 95.2 0.99 94.6 95.2 0.96 95.4
SRR3135172 21164226 90.1 1.00 74.6 90.1 0.99 75.6
Sample
PKNH, Plasmodium knowlesi  H strain 
Supplementary Table S1. Illumina sequenced Plasmodium knowlesi samples used in this study to 
support new reference generation.
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Supplementary Table 2 from this article has the following title: “Supplementary Table S2. 
Methylated sites identified in Plasmodium knowlesi data from our study, and their presence in the 
re-analysed clone described in Moon et al. (2016).” and can be found following this link 
(https://ars.els-cdn.com/content/image/1-s2.0-S0020751917303466-mmc2.xlsx). It will not be 
printed here given it is composed of 40,000 rows and was uploaded to the journal as an EXCEL table. 
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Supplementary Table S3. Methylated sites identified in Plasmodium knowlesi in our study and the re-analysed clone data 
from Moon et al. (2016). Highlighted in bold the relevant genes with functions related to ribosomal function, methylation, 
DNA interactions and invasion. 
 
Chromosome 
Position 
start 
window 
Position end 
window 
Modifications 
(this study) 
Modifications 
(Moon et al., 
2016) 
Deviation 
from 
chromosomal 
mean (this 
study) 
Deviation 
from 
chromosomal 
mean  (Moon 
et al., 2016) Gene IDs Products 
PKNH_01_v2 90001 100000 41 73 2.39 1.08 
PKNH_0101800 
/PKNH_0101900 
/PKNH_0102000 
/PKNH_0102100 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_01_v2 220001 230000 50 94 2.92 1.4 
PKNH_0103500 
/PKNH_0103600 
/PKNH_0103700 
methyltransferase, 
putative/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_01_v2 300001 310000 37 113 2.16 1.68 
PKNH_0105200 
/PKNH_0105700 
DNA mismatch repair 
protein MSH2, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_01_v2 410001 420000 38 68 2.22 1.01 
PKNH_0108300 
/PKNH_0108400 
lysophospholipase, 
putative/lysophospholipase, 
putative 
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PKNH_01_v2 810001 820000 40 84 2.34 1.25 
PKNH_0117200 
/PKNH_0117400 
sentrin-specific protease 2, 
putative (SENP2)/nucleolar 
protein 10, putative (NOL10) 
PKNH_02_v2 480001 490000 42 80 2.42 1.29 
PKNH_0210600 
/PKNH_0210700 
/PKNH_0210800 
vacuolar protein sorting-
associated protein VTA1, 
putative/aspartate--tRNA 
ligase, putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_02_v2 540001 550000 13 124 0.75 2 
PKNH_0211700 
/PKNH_0211800 
/PKNH_0211900 
/PKNH_0212000 
conserved Plasmodium 
protein, unknown 
function/cysteine desulfurase, 
putative (NFS)/DNA 
(cytosine-5)-
methyltransferase, putative 
(DNMT)/proteasome subunit 
alpha type-5, putative 
PKNH_03_v2 230001 240000 38 79 2.30 1.26 
PKNH_0304200 
/PKNH_0304300 
/PKNH_0304400 
V-type proton ATPase subunit 
B, putative/sexual stage-
specific protein precursor, 
putative/cytosolic glyoxalase 
II, putative (cGloII) 
PKNH_03_v2 260001 270000 37 64 2.24 1.02 
PKNH_0304900 
/PKNH_0305000 
/PKNH_0305100 
/PKNH_0305200 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/methyltransferase, 
putative/peptidyl-tRNA 
hydrolase 2, putative (PTH2) 
PKNH_03_v2 310001 320000 44 97 2.66 1.55 
PKNH_0306400 
/PKNH_0306500 conserved Plasmodium 
protein, unknown function/flap 
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endonuclease 1, putative 
(FEN1) 
PKNH_03_v2 460001 470000 42 104 2.54 1.66 
PKNH_0310200 
/PKNH_0310300 
/PKNH_0310400 
conserved Plasmodium 
protein, unknown 
function/ribosomal protein, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_03_v2 750001 760000 49 113 2.96 1.81 
PKNH_0315000 
/PKNH_0315100 
/PKNH_0315200 
60S ribosomal protein L11a, 
putative/40S ribosomal 
protein S10, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_04_v2 160001 170000 38 52 2.39 0.73 
PKNH_0404100 
/PKNH_0404200 
conserved Plasmodium 
protein, unknown 
function/autophagy-related 
protein 11, putative (ATG11) 
PKNH_04_v2 170001 180000 38 58 2.39 0.81 
PKNH_0404300 
/PKNH_0404400 
MtN3/saliva family, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_04_v2 780001 790000 37 76 2.33 1.07 
PKNH_0418100 
/PKNH_0418200 
/PKNH_0418300 
/PKNH_0418400 
repetitive organellar protein, 
putative 
(ROPE)/palmitoyltransferase, 
putative (DHHC12)/conserved 
Plasmodium protein, unknown 
function/octaprenyl 
pyrophosphate synthase, 
putative (OPP) 
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PKNH_04_v2 1010001 1020000 11 155 0.69 2.17 
PKNH_0422400 
/PKNH_0422500 
/PKNH_0422600 
GTPase Era, putative 
(ERA)/conserved Plasmodium 
protein, unknown 
function/glucose-6-phosphate 
isomerase 
PKNH_05_v2 110001 120000 29 86 2.10 1.49 PKNH_0502300 
rhoptry neck protein 5, 
putative (RON5) 
PKNH_05_v2 230001 240000 15 116 1.09 2.01 
PKNH_0505400 
/PKNH_0505500 
/PKNH_0505600 
50S ribosomal protein L10, 
putative/ubiquitin carboxyl-
terminal hydrolase 13, 
putative 
(USP13)/chromosome 
associated protein, putative 
PKNH_05_v2 570001 580000 28 74 2.03 1.28 
PKNH_0512300 
/PKNH_0512400 
/PKNH_0512500 
ran binding protein 1, 
putative/apical merozoite 
protein, putative (Pk34)/60S 
ribosomal protein 
L7ae/L30e, putative 
PKNH_05_v2 600001 610000 32 62 2.32 1.07 
PKNH_0512700 
/PKNH_0512800 
zinc finger protein, 
putative/serine/threonine 
protein kinase RIO2, putative 
(RIO2) 
PKNH_05_v2 710001 720000 14 123 1.02 2.13 
PKNH_0514600 
/PKNH_0514700 
/PKNH_0514800 
/PKNH_0514900 
/PKNH_0515000 
/PKNH_0515100 
eukaryotic initiation factor, 
putative/serpentine receptor, 
putative (SR12)/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/AP-4 complex 
subunit sigma, 
putative/conserved 
 51 
Plasmodium protein, unknown 
function 
PKNH_06_v2 220001 230000 45 57 2.66 0.86 
PKNH_0605300 
/PKNH_0605400 
/PKNH_0605500 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_06_v2 570001 580000 34 65 2.01 0.98 
PKNH_0612900 
/PKNH_0613000 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_07_v2 280001 290000 53 142 2.98 1.99 
PKNH_0705200 
/PKNH_0705300 
/PKNH_0705400 
ATP-dependent protease 
ATPase subunit ClpY, 
putative (ClpY)/conserved 
Plasmodium protein, unknown 
function/translation initiation 
factor SUI1, putative 
PKNH_07_v2 1180001 1190000 42 78 2.36 1.09 
PKNH_0726600 
/PKNH_0726700 
/PKNH_0726800 
/PKNH_0726900 
/PKNH_0727000 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
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PKNH_08_v2 240001 250000 36 75 2.25 1.17 
PKNH_0804700 
/PKNH_0804800 
/PKNH_0804900 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/CCR4-NOT 
transcription complex 
subunit 5, putative (NOT5) 
PKNH_08_v2 350001 360000 13 164 0.81 2.55 PKNH_0807600 
zinc finger C-x8-C-x5-C-x3-H 
type, putative 
PKNH_08_v2 500001 510000 33 100 2.06 1.56 
PKNH_0811300 
/PKNH_0811400 
/PKNH_0811500 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/DNA repair protein 
RAD23, putative 
PKNH_08_v2 600001 610000 39 83 2.44 1.29 
PKNH_0813500 
/PKNH_0813600 
/PKNH_0813700 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/initiation factor 2 
subunit family, putative 
PKNH_08_v2 1090001 1100000 35 64 2.19 1 
PKNH_0823500 
/PKNH_0823600 
DNA-directed RNA 
polymerase II subunit 
RPB1, putative (RPB1)/KIR 
protein 
PKNH_08_v2 1400001 1410000 35 102 2.19 1.59 
PKNH_0830400 
/PKNH_0830500 
/PKNH_0830600 
/PKNH_0830700 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved protein, 
unknown function/aspartyl 
protease, putative 
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PKNH_08_v2 1680001 1690000 44 109 2.75 1.7 
PKNH_0837400 
/PKNH_0837500 
/PKNH_0837600 
conserved Plasmodium 
membrane protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_09_v2 270001 280000 40 101 2.21 1.45 
PKNH_0905300 
/PKNH_0905400 
pescadillo homolog, putative 
(PES)/transcription factor with 
AP2 domain(s), putative 
(ApiAP2) 
PKNH_09_v2 720001 730000 40 58 2.21 0.83 
PKNH_0915800 
/PKNH_0915900 
/PKNH_0916000 
AP-1 complex subunit sigma, 
putative/heat shock protein 
90, putative/insulinase, 
putative 
PKNH_09_v2 830001 840000 38 63 2.10 0.9 
PKNH_0918700 
/PKNH_0918800 
/PKNH_0918900 
/PKNH_0919000 
palmitoyltransferase, putative 
(DHHC3)/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/tyrosine kinase-like 
protein, putative (TKL2) 
PKNH_09_v2 1440001 1450000 21 142 1.16 2.04 PKNH_0932400 
conserved Plasmodium 
protein, unknown function 
PKNH_09_v2 1660001 1670000 38 66 2.10 0.95 PKNH_0937000 
WD repeat-containing protein, 
putative 
PKNH_09_v2 1960001 1970000 38 96 2.10 1.38 
PKNH_0943000 
/PKNH_0943100 
coatomer subunit gamma, 
putative 
(SEC21)/serine/threonine 
protein kinase, putative 
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PKNH_09_v2 2010001 2020000 49 81 2.71 1.16 PKNH_0944300 
leucine-rich repeat protein 
(LRR10) 
PKNH_09_v2 2110001 2120000 46 95 2.55 1.36 PKNH_0946100 
conserved Plasmodium 
protein, unknown function 
PKNH_09_v2 2130001 2140000 44 34 2.44 0.49 PKNH_0946200 
conserved Plasmodium 
protein, unknown function 
PKNH_10_v2 540001 550000 37 74 2.15 1.06 
PKNH_1011700 
/PKNH_1011800 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_10_v2 1090001 1100000 41 90 2.38 1.29 
PKNH_1023800 
/PKNH_1023900 
/PKNH_1024000 
phosphatidylinositol 4-kinase, 
putative (PI4K)/conserved 
Plasmodium protein, unknown 
function/asparagine--tRNA 
ligase, putative 
PKNH_10_v2 1390001 1400000 41 106 2.38 1.52 
PKNH_1030600 
/PKNH_1030700 
merozoite surface protein 3, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_10_v2 1410001 1420000 39 74 2.26 1.06 
PKNH_1031200 
/PKNH_1031300 
/PKNH_1031400 
/PKNH_1031500 
hypothetical protein, 
conserved in Apicomplexan 
species/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/merozoite surface 
protein 8, putative (MSP8) 
PKNH_10_v2 1420001 1430000 38 112 2.21 1.6 PKNH_1031500 
/PKNH_1031600 
merozoite surface protein 8, 
putative (MSP8)/conserved 
Plasmodium protein, unknown 
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/PKNH_1031700 
/PKNH_1031800 
function/conserved 
Plasmodium protein, unknown 
function/HCNGP-like protein, 
putative 
PKNH_11_v2 300001 310000 35 105 2.30 1.59 
PKNH_1107200 
/PKNH_1107300 
/PKNH_1107400 
6-cysteine protein 
(P92)/conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_11_v2 320001 330000 34 80 2.24 1.21 
PKNH_1107700 
/PKNH_1107800 
/PKNH_1107900 
/PKNH_1108000 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/polyubiquitin binding 
protein, putative (DOA1)/50S 
ribosomal protein L9, 
mitochondrial, putative 
PKNH_11_v2 460001 470000 18 140 1.19 2.12 
PKNH_1110700 
/PKNH_1110800 
E3 SUMO-protein ligase 
PIAS, putative 
(PIAS)/guanylyl cyclase, 
putative 
PKNH_11_v2 500001 510000 35 108 2.30 1.64 
PKNH_1111500 
/PKNH_1111600 
ADP-ribosylation factor, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_11_v2 680001 690000 33 62 2.17 0.94 
PKNH_1114700 
/PKNH_1114800 
serine/threonine protein 
kinase, putative (ARK3)/DNAJ 
like protein, putative 
PKNH_11_v2 1700001 1710000 34 67 2.24 1.02 
PKNH_1137000 
/PKNH_1137100 conserved Plasmodium 
protein, unknown 
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function/nucleolar GTP-
binding protein 1, putative 
PKNH_11_v2 1710001 1720000 31 98 2.04 1.49 
PKNH_1137200 
/PKNH_1137300 
/PKNH_1137400 
/PKNH_1137500 
/PKNH_1137600 
6-cysteine protein (P12p)/6-
cysteine protein (P12)/PP-
loop family protein, 
putative/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_11_v2 2120001 2130000 42 48 2.77 0.73 
PKNH_1144900 
/PKNH_1145000 
nucleoside diphosphate 
kinase, putative/cyclin 
dependent kinase binding 
protein, putative 
PKNH_12_v2 700001 710000 40 124 2.23 1.71 
PKNH_1215700 
/PKNH_1215800 
/PKNH_1215900 
dynein beta chain, 
putative/aspartyl protease, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_12_v2 760001 770000 36 77 2.00 1.06 
PKNH_1217000 
/PKNH_1217200 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_12_v2 920001 930000 44 123 2.45 1.7 
PKNH_1219600 
/PKNH_1219700 
/PKNH_1219800 
/PKNH_1219900 
conserved Plasmodium 
protein, unknown 
function/thioredoxin-like 
protein (TLP1)/valine--tRNA 
ligase, putative/conserved 
Plasmodium protein, unknown 
function 
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PKNH_12_v2 1050001 1060000 39 66 2.17 0.91 PKNH_1223800 knowpain-1 (KP1) 
PKNH_12_v2 1130001 1140000 49 77 2.73 1.06 
PKNH_1225300 
/PKNH_1225400 
/PKNH_1225500 
/PKNH_1225600 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_12_v2 1730001 1740000 43 76 2.39 1.05 
PKNH_1239200 
/PKNH_1239300 
/PKNH_1239400 
conserved Plasmodium 
protein, unknown 
function/serine/threonine 
protein kinase, putative 
(SRPK2)/protein transport 
protein SEC7, putative 
(SEC7) 
PKNH_12_v2 1750001 1760000 37 63 2.06 0.87 
PKNH_1239600 
/PKNH_1239700 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_12_v2 1760001 1770000 37 108 2.06 1.49 
PKNH_1239700 
/PKNH_1239800 
conserved Plasmodium 
protein, unknown 
function/protein 
prenyltransferase alpha 
subunit, putative 
PKNH_12_v2 1810001 1820000 36 66 2.00 0.91 PKNH_1241000 
serine/threonine protein 
kinase, putative 
 58 
PKNH_12_v2 2200001 2210000 42 74 2.34 1.02 
PKNH_1248600 
/PKNH_1248700 
/PKNH_1248800 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/U3 small nucleolar 
RNA-associated protein 15, 
putative (UTP15) 
PKNH_12_v2 2230001 2240000 41 63 2.28 0.87 
PKNH_1249300 
/PKNH_1249400 
/PKNH_1249500 
inner membrane complex 
protein 1f, putative 
(IMC1f)/glycerol kinase, 
putative/60S ribosomal 
protein L17, putative 
PKNH_12_v2 2240001 2250000 40 86 2.23 1.19 
PKNH_1249500 
/PKNH_1249600 
60S ribosomal protein L17, 
putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_12_v2 2630001 2640000 36 95 2.00 1.31 
PKNH_1257800 
/PKNH_1257900/
PKNH_1258000 
UDP-N-acetylglucosamine 
pyrophosphorylase, 
putative/conserved 
Plasmodium protein, unknown 
function/DNA repair protein 
RAD5, putative (RAD5) 
PKNH_13_v2 350001 360000 40 95 2.36 1.32 
PKNH_1307500 
/PKNH_1307600 
/PKNH_1307700 
/PKNH_1307800 
/PKNH_1307900 
tRNA delta(2)-
isopentenylpyrophosphate 
transferase, putative 
(MiaA)/blood-stage antigen 
41-3, putative/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/50S ribosomal 
protein L29, putative 
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PKNH_13_v2 400001 410000 34 64 2.01 0.89 
PKNH_1308600 
/PKNH_1308700 
conserved protein, unknown 
function/zinc finger protein, 
putative 
PKNH_13_v2 1100001 1110000 43 41 2.54 0.57 
PKNH_1324500 
/PKNH_1324600 
conserved Plasmodium 
protein, unknown 
function/Plasmodium 
exported protein (PHIST), 
unknown function 
PKNH_13_v2 1450001 1460000 36 76 2.12 1.06 
PKNH_1331100 
/PKNH_1331200 
/PKNH_1331300 
CorA-like Mg2+ transporter 
protein, putative/DNA 
mismatch repair protein 
MSH2, putative/conserved 
Plasmodium protein, unknown 
function 
PKNH_13_v2 1650001 1660000 49 52 2.89 0.72 
PKNH_1336600 
/PKNH_1336900 
/PKNH_1337000 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_13_v2 1860001 1870000 37 113 2.18 1.57 
PKNH_1341400 
/PKNH_1341500 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_13_v2 1920001 1930000 36 51 2.12 0.71 PKNH_1342600 
conserved Plasmodium 
protein, unknown function 
PKNH_13_v2 2250001 2260000 44 99 2.60 1.38 
PKNH_1349600 
/PKNH_1349700 
conserved Plasmodium 
protein, unknown 
function/conserved 
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Plasmodium protein, unknown 
function 
PKNH_13_v2 2340001 2350000 20 151 1.18 2.1 
PKNH_1351200 
/PKNH_1351300 
/PKNH_1351400 
radical SAM protein, 
putative/glideosome 
associated protein with 
multiple membrane spans 3, 
putative (GAPM3)/vacuolar 
protein sorting-associated 
protein 29, putative (VPS29) 
PKNH_13_v2 2380001 2390000 49 103 2.89 1.43 
PKNH_1352100 
/PKNH_1352200 
/PKNH_1352300 
RNA-binding protein, 
putative/RNA-binding 
protein, putative/ribosome 
biogenesis protein BOP1, 
putative (BOP1) 
PKNH_13_v2 2400001 2410000 38 71 2.24 0.99 
PKNH_1352500 
/PKNH_1352600 
/PKNH_1352800 
ribonucleotide reductase 
small subunit, putative/COBW 
domain-containing protein 1, 
putative (CBWD1)/conserved 
Plasmodium protein, unknown 
function 
PKNH_13_v2 2420001 2430000 39 92 2.30 1.28 
PKNH_1353100 
/PKNH_1353200 
/PKNH_1353300 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_14_v2 740001 750000 40 85 2.25 1.18 
PKNH_1416300 
/PKNH_1416400 
/PKNH_1416500 
CDP-diacylglycerol--inositol 3-
phosphatidyltransferase 
(PIS)/tRNA (adenine(58)-
N(1))-methyltransferase 
catalytic subunit TRM61, 
putative 
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(GCD14)/transcription factor 
MYB1, putative (MYB1) 
PKNH_14_v2 900001 910000 39 91 2.19 1.26 
PKNH_1420200 
/PKNH_1420300 
/PKNH_1420400 
conserved Plasmodium 
protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function 
PKNH_14_v2 2000001 2010000 30 52 1.68 0.72 
PKNH_1445800 
/PKNH_1445900 
/PKNH_1446000 
conserved Plasmodium 
protein, unknown 
function/RAP protein, 
putative/proliferating cell 
nuclear antigen 2, putative 
(PCNA2) 
PKNH_14_v2 2830001 2840000 39 89 2.19 1.23 PKNH_1463300 
glucose inhibited division 
protein a homologue, putative 
PKNH_14_v2 3020001 3030000 39 58 2.19 0.8 
PKNH_1467900 
/PKNH_1468000 
/PKNH_1468100 
/PKNH_1468200 
RNA-binding protein, 
putative/conserved 
Plasmodium protein, unknown 
function/conserved 
Plasmodium protein, unknown 
function/bax inhibitor 1, 
putative 
PKNH_14_v2 3200001 3210000 47 75 2.64 1.04 
PKNH_1472300 
/PKNH_1472400 
reticulocyte binding protein 
(NBPXa)/tryptophan-rich 
antigen 
Reference 
        
 62 
Moon, R. W., Sharaf, H., Hastings, C. H., Ho, Y. S., Nair, M. B., Rchiad, Z., Knuepfer, E., Ramaprasad, A., Mohring, F., 
Amir, A., Yusuf, N. A., Hall, J., Almond, N., Lau, Y. L., Pain, A., Blackman, M. J., Holder, A. A., 2016. Normocyte-binding 
protein required for human erythrocyte invasion by the zoonotic malaria parasite Plasmodium knowlesi. Proc Natl Acad Sci 
U S A, 113, 7231–7236.  
 
 63 
RESEARCH PAPER COVER SHEET 
 
PLEASE NOTE THAT A COVER SHEET MUST BE COMPLETED FOR EACH RESEARCH PAPER INCLUDED IN A 
THESIS. 
 
SECTION A – Student Details 
 
Student Ernest Diez Benavente 
Principal Supervisor Taane Clark & Susana Campino 
Thesis Title 
Using whole genome sequence data to study genomic diversity 
and develop molecular barcodes to profile Plasmodium malaria 
parasites 
 
If the Research Paper has previously been published please complete Section B, if not please move to Section 
C 
 
SECTION B – Paper already published 
 
Where was the work published? PLOS Genetics 
When was the work published? September 2017 
If the work was published prior to 
registration for your research degree, give 
a brief rationale for its inclusion 
      
Have you retained the copyright for the 
work?* 
Yes 
Was the work subject to 
academic peer review? 
Yes 
 
 
*If yes, please attach evidence of retention. If no, or if the work is being included in its published format, please 
attach evidence of permission from the copyright holder (publisher or other author) to include this work. 
 
SECTION C – Prepared for publication, but not yet published 
 
Where is the work intended to be 
published? 
      
Please list the paper’s authors in the 
intended authorship order: 
      
 64 
Stage of publication Choose an item. 
 
SECTION D – Multi-authored work 
 
For multi-authored work, give full 
details of your role in the research 
included in the paper and in the 
preparation of the paper. (Attach a 
further sheet if necessary) 
I downloaded the raw data from public repositories. I created the pipeline in 
which I ran the samples through and performed the QC analysis, as well as the 
interpretation analysis. I later created custom R and perl scripts to process the 
data in order to obtain information related to coverage, SNPs and other 
genomic information. The figures presented in this work have all been 
generated using scripts written by myself or publicly available software adapted 
for this purpose. I wrote the first draft of the manuscript and circulated to co-
authors. Once the comments were received I gathered them and made the 
relevant changes on the article manuscript. I then performed the submission of 
the work to the PLOS Genetics journal and once comments from reviewers 
arrived, I made the corresponding changes and corrections. 
 
 
Student Signature:        Date:     
 
Supervisor Signature:        Date:   _______ 
  
 65 
 
 
 
 
 
Chapter 3 
Analysis of nuclear and organellar genomes of 
Plasmodium knowlesi in humans reveals 
ancient population structure and recent 
recombination among host-specific 
subpopulations  
 66 
  
 67 
 
  
 68 
 
  
 69 
 
  
 70 
 
  
 71 
 
  
 72 
 
  
 73 
  
 74 
 
  
 75 
 
  
 76 
 
  
 77 
  
 78 
 
  
 79 
 
  
 80 
 
  
 81 
  
 82 
Supplementary Information 
 
Supplementary Figure 1: Geographical source of the P. knowlesi isolates: Betong (n = 14), Kapit (n = 
33) and Sarikei (n = 6). 
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Supplementary Figure 2: Evaluation of multiplicity of infection (MOI) using mixed genotype calls (x-
axis) and the estMOI read-pair haplotype counting approach [45] (y-axis) reveals seven highly non-
clonal samples. 
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Supplementary Figure 3: Principal components analysis of the M. fascicularis P. knowlesi genotype 
group (Mf-Pk, Cluster 1) confirms that the subgroups from Kapit and Betong are separated. 
The Mf-Pk Sarikei samples (DIM code in orange) cluster with either one of the two groups, which is 
consistent with the geographic location of Sarikei as an equidistant region between Kapit and 
Betong. There is increased diversity of Betong samples compared to the Kapit samples. 
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Supplementary Figure 4: Genome-wide differences in allele frequencies (measured using the 
fixation index (FST)) between M. fascicularis P. knowlesi genotype groups (Mf-Pk) from Kapit and 
Betong. 
The comparison shows clear abnormalities in several genomic regions in chromosome 8 shown to be 
a result of genetic exchange with the Mn-Pk genotype. 
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Supplementary Figure 5: Transcriptomic profiles for the orthologues of the introgressed genes 
under selection pressure. 
The transcriptomic profiles of the orthologues in P. falciparum [26] and P. berghei [27] for the three 
genes found to be under strong selection pressure were extracted from PlasmoDB 
(http://plasmodb.org/plasmo/), including the percentile and the Fragments Per Kilobase of 
transcript per Million mapped reads (FPKM) plots. These included data for 5 P. berghei stages (4-
hour Ring, 16-hour Trophozoite, 22-hour Schizont, Gametocyte and Ookinete) and 7 P. falciparum 
stages (Ring, early Trophozoite, late Trophozoite, Schizont, Gametocyte stage II, Gametocyte stage V 
and Ookinete), and showing a clear increased expression in mosquito related stages, particularly the 
ookinete stage. 
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Supplementary Figure 6: Genome distribution of introgression events for each chromosome 
estimated using SNP diversity in 50Kb sliding windows. 
(Left panel) location of introgressions from M. nemestrina P. knowlesi (Mn-Pk) genotype into M. 
fasciscularis P. knowlesi (Mf-Pk) genotypes, a dashed shaded region has been added where at least 1 
gene related with the ookinete life stage of the parasite has been identified based on gene 
expression for the orthologue genes in P. berghei and/or P. falciparum. (Right panel) location of 
introgressions from Mf-Pk genotype into Mn-Pk genotypes. 
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Supplementary Figure 7:  Analysis of organellar mitochondria (MIT) and apicoplast (Api) SNPs 
confirms clustering into three core haplotype groups a) Haplotype plot for the 36 samples with 
sufficient coverage across the organellar genomes. Three clearly defined clusters are present. The 
first cluster represents the mitochondrial genotype found in the Peninsular strains (purple, n = 5) 
and a set of 10 samples with a highly related haplotype with the smallest inter-cluster average FST 
(average FST = 0.16) from Borneo Malaysia (represented in red in Fig 2). The second cluster (green in 
Fig 2) includes the majority of M. nemestrina P. knowlesi (Mn-Pk) nuclear genotype isolates. The 
third cluster (blue in Fig 2) consists only of isolates with Mf-Pk nuclear genotypes. The presence of 
samples in the other two clusters with mismatched nuclear and organellar genomes indicates that 
these two subpopulations have undergone genetic exchange. b) Phylogenetic tree generated using 
362 apicoplast SNPs. The tree shows a very similar pattern of clustering to Fig 2. 
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Supplementary Table 1: Study samples. 
Sample Code Area Host MOI* 
Group 
**  
Total 
Reads 
Mapped 
Reads % 
Genome 
covered 
Cover. 
Mean 
Ex∆
*** Year 
ERR274221 DIM1 Sarikei Human 0.8 Mf 46353062 96.9 0.99 174.1 Yes 2012/3 
ERR274222 DIM2 Sarikei Human 0.7 Mf 60189967 97.7 0.99 228.7 Yes 2012/3 
ERR274224 DIM3 Sarikei Human 0.6  Mn 42350437 97.0 0.98 161.5 Yes 2012/3 
ERR274225 DIM4 Sarikei Human 0.5 Mn 52883838 97.2 0.98 201.6 Yes 2012/3 
ERR366425 DIM5 Sarikei Human 0.3 Mn 6391836 97.1 0.95 36.0 Yes 2012/3 
ERR366426 DIM6 Sarikei Human 0.2 Mf 6270503 94.8 0.95 34.1 Yes 2012/3 
ERR985372 BTG1000 Betong Human 0.8 Mf 30620879 66.0 0.98 79.7 Yes 2012/3 
ERR985374 BTG26 Betong Human 1.6 Mf 55120863 96.4 0.99 207.5 Yes 2012/3 
ERR985375 BTG35 Betong Human 6.8 Mf 66747737 22.7 0.98 55.4 Yes 2012/3 
ERR985376 BTG39 Betong Human 9.9 Mf 50924729 79.3 0.99 157.7 Yes 2012/3 
ERR985377 BTG42 Betong Human 1.0 Mf 71277238 95.3 0.99 248.7 Yes 2012/3 
ERR985378 BTG46 Betong Human 1.4 Mf 47365570 95.6 0.99 177.7 Yes 2012/3 
ERR985379 BTG47 Betong Human 1.2 Mf 40897898 95.5 0.99 153.6 Yes 2012/3 
ERR985380 BTG49 Betong Human 5.9 Mf 61989913 97.2 1 234.8 Yes 2012/3 
ERR985381 BTG50 Betong Human 1.4 Mf 51234398 94.9 0.99 189.9 Yes 2012/3 
ERR985382 BTG53 Betong Human 1.3 Mf 48838502 49.6 0.98 89.3 Yes 2012/3 
ERR985383 BTG55 Betong Human 3.6 Mf 40307405 85.8 0.99 126.8 Yes 2012/3 
ERR985384 BTG62 Betong Human 3.0 Mf 52753853 88.0 0.99 167.0 Yes 2012/3 
ERR985385 CDK88 Kapit Human 1.1 Mf 93728041 60.6 1 213.1 No 2012/3 
ERR985386 KT03 Kapit Human 22.8 Mf 52908664 22.3 0.98 45.3 No 2012/3 
ERR985387 KT04 Kapit Human 2.7 Mf 48092075 91.8 0.99 173.0 No 2012/3 
ERR985388 KT06 Kapit Human 1.0 Mf 68600487 92.2 0.99 247.4 No 2012/3 
ERR985394 KT12 Kapit Human 1.0 Mf 26219163 95.2 0.98 99.0 No 2012/3 
ERR985395 KT26 Kapit Human 50.4 Mf 45997535 86.1 1 154.6 No 2012/3 
ERR985396 KT29 Kapit Human 21.0 Mf 31849384 60.9 0.99 76.4 No 2012/3 
ERR985397 KT30 Kapit Human 22.3 Mf 40463921 92.0 1 146.3 No 2012/3 
ERR985398 KT34 Kapit Human 1.2 Mf 33387794 61.2 0.98 80.5 Yes 2012/3 
ERR985399 KT40 Kapit Human 1.3 Mf 34420982 97.0 0.99 131.2 No 2012/3 
ERR985400 KT48 Kapit Human 1.0 Mf 36366112 84.6 0.99 121.4 No 2012/3 
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ERR985401 KT50 Kapit Human 1.0 Mf 36045889 95.3 0.99 135.9 Yes 2012/3 
ERR985402 KT57 Kapit Human 0.7 Mf 56171218 92.5 0.99 202.0 No 2012/3 
ERR985403 KT72 Kapit Human 0.6 Mf 52517284 95.4 0.99 193.6 No 2012/3 
ERR985404 KT73 Kapit Human 1.2 Mf 52157592 94.6 1 190.2 No 2012/3 
ERR985410 BTG44 Betong Human 32.7 Mn 32160549 97.1 0.99 122.9 No 2012/3 
ERR985411 BTG63 Betong Human 0.8 Mn 54179835 80.4 0.98 161.6 Yes 2012/3 
ERR985412 CDK206 Kapit Human 0.8 Mn 66023442 44.2 0.99 109.4 Yes 2012/3 
ERR985414 KT25 Kapit Human 0.8 Mn 65300398 93.9 0.99 242.3 Yes 2012/3 
ERR985415 KT27 Kapit Human 0.9 Mn 60931327 92.5 0.99 223.7 Yes 2012/3 
ERR985416 KT31 Kapit Human 1.2 Mn 78064720 92.6 0.99 286.4 Yes 2012/3 
ERR985417 KT42 Kapit Human 29.9 Mn 41500510 95.7 0.99 157.1 No 2012/3 
ERR985418 KT55 Kapit Human 0.7 Mn 54311715 89.9 0.98 191.6 Yes 2012/3 
ERR985419 KT56 Kapit Human 4.5 Mn 57630655 81.2 0.99 183.6 Yes 2012/3 
ERR985373 BTG123 Betong Human 0.7 Mf 42713162 78.6 0.98 119.3 Yes 2012/3 
ERR985389 KT100 Kapit Human 2.8 Mf 41469453 86.3 0.99 126.4 Yes 2012/3 
ERR985390 KT103 Kapit Human 0.5 Mf 41673914 83.2 0.99 117.2 No 2012/3 
ERR985391 KT107 Kapit Human 0.6 Mf 40562077 90.6 0.99 141.0 No 2012/3 
ERR985392 KT109 Kapit Human 0.6 Mf 42267002 87.0 0.99 132.1 Yes 2012/3 
ERR985393 KT120 Kapit Human 0.5 Mf 34929904 71.1 0.98 88.5 No 2012/3 
ERR985405 KT77 Kapit Human 30.9 Mf 38834680 88.7 1 128.1 No 2012/3 
ERR985406 KT81 Kapit Human 0.5 Mf 47157966 83.6 0.99 138.9 No 2012/3 
ERR985407 KT92 Kapit Human 0.8 Mf 43617554 86.2 0.99 135.2 Yes 2012/3 
ERR985408 KT94 Kapit Human 0.6 Mf 47394270 86.8 0.99 148.1 Yes 2012/3 
ERR985409 KT95 Kapit Human 3.5 Mf 50949905 80.5 0.99 134.1 Yes 2012/3 
ERR985413 KT114 Kapit Human 0.5 Mn 51040091 74.5 0.98 119.8 No 2012/3 
SRR2221468 Hackeri Penin. Rh mac 1.2 Penin. 22542689 94.5 0.99 83.2 No 1960s 
SRR2222335 H(AW) Penin Rh mac 0 Penin. 23371486 96.1 1 89.6 No 1960s 
SRR2225467 Malayan Penin. Rh mac 10.7 Penin. 19455031 79.3 1 60.9 No 1960s 
SRR2225571 MR4-H Penin. Rh mac 0.6 Penin. 22264926 74.6 0.98 64.0 No 1960s 
SRR2225573 Philipp. Penin. Rh mac 0.8 Penin. 25538996 95.2 0.99 94.6 No 1960s 
SRR3135172 YH1 Penin. Rh mac 5.6 Penin. 21164226 90.1 1 74.6 No 1960s 
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* Multiplicity of infection (MOI) is % of genome presenting multiplicity of infection; **Group 
established by whole Genome PCA: Mf M. fascicularis, Mn M. nemestrina, Penin. Peninsular; Rh mac 
Rhesus macaque, *** evidence of genetic exchange (ExΔ) 
 
 
Supplementary Table 2 from this article has the following title: “Supplementary Table 2. 50 Kb 
regions in the P. knowlesi genome that present genetic exchanges in the full set of samples” and can 
be found following this link (https://ndownloader.figshare.com/files/9430912). It will not be printed 
here given it is composed of 495 rows and was uploaded to the journal as an EXCEL table. 
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ABSTRACT 
Plasmodium knowlesi, a zoonotic malaria parasite, is the most common cause of human 
malaria in Malaysia. Genetic analysis has shown that the parasites are divided into three 
subpopulations according to their geographic origin (Peninsular or Borneo) and, in Borneo, their 
macaque host (Macaca fascicularis or M. nemestrina). Recent evidence suggests that genomic 
exchange events have occurred between the two host-specific subpopulations in Borneo, 
potentially reflecting adaption to host-vector-parasite interactions in a setting of ecological 
transition. However, the picture is less clear in Peninsular strains, which have been neglected in 
genomic studies. One difficulty is that genome sequencing requires sufficient high-quality 
biological material, but P. knowlesi infected individuals tend to present with low parasitaemias 
leading to samples with high human DNA contamination. Here, using a parasite selective whole 
genome amplification approach on unprocessed blood samples with high concentrations of 
human DNA, we were able to analyse recent P. knowlesi genomes sourced from both Peninsular 
Malaysia and Borneo. The high-quality data generated provides evidence that recombination 
events are also found in the Peninsular Malaysia parasite subpopulation. These parasites have 
acquired fragments of the M. nemestrina associated subpopulation genotype, including the 
DBP and NBPXa genes, which encode proteins involved in erythrocyte invasion. Furthermore, 
comprehensive characterization of the invasion genes revealed that NBPXb has also been 
exchanged within the monkey host-associated subpopulations of Malaysian Borneo. Our work 
provides strong evidence that exchange events are far more ubiquitous than expected and 
should be taken into consideration when studying the highly complex P. knowlesi population 
genomic structure. 
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INTRODUCTION 
Plasmodium knowlesi, a common malaria parasite of long-tailed (Macaca fascicularis) and pig-
tailed (M. nemestrina) macaques, is now recognized as a significant cause of human malaria. 
Reported across all countries of Southeast Asia, P. knowlesi is now the predominant cause of 
malaria in Malaysia 1–4. Severe disease occurs in 6-9% of clinical presentations and fatalities are 
well-described 1,5,6. Rapid human population growth, deforestation and encroachment on wild 
macaque habitats are thought to increase contact with humans and drive up the incidence of 
human P. knowlesi infections 10,11. Regional elimination efforts have targeted P. falciparum and 
P. vivax transmission, with significant progress demonstrated by the near-elimination of these 
Plasmodium species from areas such as Malaysian Borneo 3,4,9.  However, due to the difficulties 
in reducing the monkey parasite reservoir, it is unclear if similar control approaches are able to 
limit the risk for humans acquiring P. knowlesi malaria 12,13. 
 
Appropriate molecular tools and sampling are needed to assist surveillance of P. knowlesi by 
malaria control programs, and to understand its genetic diversity and transmission. P. knowlesi 
genomics could lead to biological insights informing control measures. Advances in whole 
genome sequencing (WGS) technologies have led to the characterization of single nucleotide 
polymorphisms (SNPs) across P. falciparum and P. vivax, with an improved understanding of 
their population structure and diversity, as well as loci underpinning drug resistance (e.g. 14–19). 
For P. knowlesi WGS studies, sample sizes have been small (n<70), but revealed that this parasite 
species is more polymorphic than P. falciparum  and  that three main subpopulations exist based 
on geographical source (Peninsular-Malaysia vs. Malaysian Borneo) and, within Malaysian 
Borneo, different hosts (M. nemestrina [Mn-Pk] and M. fascicularis [Mf-Pk] macaques, and 
humans) 20–22. These studies have also provided evidence that P. knowlesi nuclear genomes are 
not genetically isolated, but also have chromosomal-segment exchanges between 
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subpopulations 20–22. This observation points to subpopulations that have diverged in isolation 
and then re-connected, possibly due to deforestation and disruption of wild macaque habitats. 
The resulting genomic mosaics reveal traits selected by host-vector-parasite interactions in a 
setting of ecological transition. However, despite these insights, P. knowlesi isolates from both 
monkeys and humans in Peninsular Malaysia are under-represented in analyses, and the genetic 
diversity in that region is less clear. 
 
One roadblock to large-scale genomic studies of clinical P. knowlesi parasites is that the majority 
of infections have low parasitaemias, leading to samples with high levels of human compared to 
parasite DNA.  Until now the WGS data for Plasmodium parasites has been obtained from venous 
blood of clinical cases that were filtered to remove human leukocytes, and therefore reduce 
human DNA “contamination”. However, this approach does not always yield sufficient parasite 
DNA for WGS. Recently, a selective whole genome amplification (SWGA) strategy has been used 
to sequence P. falciparum and P. vivax genomes from non-filtered blood and from dried blood 
spots of clinical samples 23–25. The SWGA method uses oligonucleotides that preferentially bind 
with high frequency to the target DNA, but less frequently to the “contaminating” genome 26. 
The high fidelity Phi29 polymerase is then used to amplify long segments of DNA. Here we 
developed an SWGA approach for P. knowlesi, and sequenced 26 isolates across Malaysia, 
including both Peninsular and Borneo, revealing new insights into the population structure and 
evolution of this parasite.  
 
RESULTS 
Selective whole genome amplification of P. knowlesi parasite DNA from clinical samples 
We performed SWGA on P. knowlesi DNA samples obtained directly from human blood using six 
selected primers that specifically amplified this parasite genome and bind less frequently to the 
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human genome (See Materials and Methods). The primer set had a mean binding frequency of 
at least once every 4,826bp to the P. knowlesi genome, much higher than the once every 
40,307bp to the human genome. Binding sites sufficiently near each other, as obtained with the 
primer set for P. knowlesi, enable the branching and displacement actions of the Phi29 
polymerase and increase the success of the genome amplification27.  
 
For 10 samples, we performed WGS on both the non-amplified and the SWGA DNA. Both sets 
of samples sequenced at a similar depth, and we observed a significant increase (mean 7.7-fold 
more) in the proportion of reads that mapped to the P. knowlesi A1-H.1 reference genome after 
DNA amplification (Table 1, showing only non-pooled sequencing results). As a result, amplified 
samples have higher genome coverage (mean 6.8-fold greater) and a much higher number of 
callable SNPs (mean 182-fold greater, with an average of 14,078 SNPs for no SWGA vs. 115,995 
SNPs for SWGA) (Table 1).  Gene regions presented with higher coverage (% of genes with 
coverage > 5-fold: average for no SWGA 5.3% vs. SWGA 43.3%) than intergenic regions (% of 
genes with coverage > 5-fold: average for no SWGA 4.1% vs. SWGA 30.4%).  DNA from a further 
16 clinical isolates underwent SWGA and WGS. A trend towards improved coverage in samples 
with higher parasitaemias was observed (R2= 0.6, Figure 1), with superior results for samples 
with 5,000 parasites/µl, consistent with data from P. vivax and P. falciparum isolates 24,25.  For 
samples with <5,000 parasites/µl results are more variable and do not correlate with an increase 
in parasitaemia. For these low-parasitaemia samples the genome coverage (> 5-fold) ranged 
from 6 to 43% after amplification, and represent an average increase of 78% in coverage 
compared to non-amplified samples, and an average of 66,143 callable SNPs over 2,908 SNPs 
for non-amplified samples (Table 1). For samples with lower parasite densities, increased 
sequencing and merging of  the resulting reads can lead to improved genome coverage, as 
shown for P. vivax 25. Evidence of mixed infections (multiclonality) was detected in 2 SWGA 
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samples, demonstrating that the method can amplify more than one clone present in an 
infection, as was observed for P. vivax amplified samples 25.   
 
P. knowlesi genetic variation and clustering of isolates 
The sequence data for the 26 new P. knowlesi isolates and 156 previously sequenced samples 
(see Materials and Methods) were mapped to the A1-H.1 reference genome 28. The new 
genomes include recently collected Peninsular Malaysian isolates (n=5) and clinical isolates from 
Sabah, Malaysia Borneo (n=21). From the resulting alignments 1,741,056 high quality SNPs were 
identified across the 14 chromosomes. Out of the 156 samples, 12 isolates with high levels of 
Multiplicity of Infection (see Supplementary figure 1) and 41 isolates with low genome coverage 
(<30%  of genome covered) were excluded; leaving 103 (20 SWGA) isolates for further analysis 
(see Supplementary table 1). A neighbour-joining tree was constructed using the SNP data 
(Figure 2) and revealed 3 predominant clusters, consistent with recent findings 20,22. In particular, 
these clusters relate to the specific geographic Peninsular-Malaysia subpopulation (purple), and 
Borneo macaque Mn-Pk (green) and Mf-Pk (blue) associated subpopulations. Furthermore, the 
tree showed a consistent positioning for SWGA isolates: 4 SWGA Peninsular isolates (red 
branches) clustered within the Peninsular Malaysia clade (purple), and of the 16 SWGA Sabah 
isolates, 2 and 14 clustered within the Mn-Pk (green) and Mf-Pk (blue) Borneo clades, 
respectively. This result demonstrates that the SWGA method can amplify all known sub-
populations of P. knowlesi. 
 
Genomic exchange events in P. knowlesi isolates from Peninsular Malaysia 
It has been shown that the subpopulations of P. knowlesi in Malaysian Borneo, although 
presenting a strong genetic differentiation, are not genetically isolated. In particular, we have 
identified genomic exchanges predominantly between the Mf-Pk and Mn-Pk clusters 20. We 
 102 
sought to investigate whether these events are also found in the clinical isolates from Peninsular 
Malaysia, by estimating SNP nucleotide diversity (SNP ) across the genome in sliding 50kb 
windows.  In two isolates (P137 and P050), we identified several regions with an exceptional 
increase in similarity with the Mn-Pk cluster and reduced similarity with the Peninsular Malaysia 
cluster (Figure 3). Analysis of the haplotypes for each individual isolate confirmed exchange 
events. The analysis of the individual sequence haplotypes of genes in the identified regions 
showed mis-clustering in a neighbour-joining tree when compared to the whole genome 
clustering patterns. These genes are represented in Supplementary Table 2. All the events 
observed were associated with introgression from Mn-Pk cluster haplotypes into the Peninsular 
Malaysia genomes and spanned mostly subtelomeric regions in chromosomes 1, 2, 7, 9, 10, 11, 
12, 13 and 14. A high proportion of Plasmodium exported proteins with unknown function were 
found to be affected by the exchange as well as tryptophan-rich antigens and 
lysophospholipases, genes associated with parasite invasion (Normocyte Binding Protein Xa 
(NBPXa), Duffy Binding Protein beta (DBP)) 29, and a cytoadherence linked asexual protein gene 
(PKNH_1401300). These results could indicate that the exchange events found in Peninsular 
Malaysia may driven by host-related factors in the erythrocytic stages of the parasite life cycle.  
 
Following the discovery of P. knowlesi invasion-related genes in the exchanged regions we 
performed a comprehensive analysis of the genetic diversity harboured by the five reticulocyte 
binding like (RBL) and Duffy binding protein like (DBP) genes involved in erythrocyte invasion: 
(A) DBPα, (B) NBPXb, (C) DBPβ, (D) DBPγ and (E) NBPXa. For each individual isolate, we compared 
its “invasion” haplotypes (Figure 4, left) to its position on neighbour-joining trees, with its 
expected clustering based on WGS data (Figure 4, right). There was a strong genetic divergence 
of the sequences from the different clusters for each of the 5 genes, with the Peninsular 
Malaysia cluster presenting with marginally greater nucleotide diversity (Peninsular Malaysia: 
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mean= 1.88x10-5; range=1.63x10-5 – 2.17x10-5) in all 5 genes when compared to the other two 
clusters (Mf-Pk: mean=1.85x10-5, range=1.15x10-5 - 2.71x10-5; Mn-Pk: mean= 1.01x10-5, 
range=0.78x10-5 - 1.42x10-5).  
 
For all the isolates, DBP and DBP gene sequence-based clusters matched those from whole 
genome data. For DBP, the overall clustering pattern was still present, but one isolate from 
Peninsular Malaysia (P050; Figure 4D, right; red star) had clear evidence of genomic exchanges 
with the Mn-Pk cluster. The longer branch length of the P050 isolate in the tree, where the 
introgression is found, reveals a stronger genetic difference compared to the other Mn-Pk DBP 
haplotypes, indicating that this exchange event could be non-recent. This observation is 
confirmed by the partial similarity of the P050 haplotype with the Mn-Pk haplotypic patterns 
(Figure 4D, left). There was also evidence of genomic exchanges events in the NBPXa, which had 
the lowest overall genetic diversity of all RBL/DBP genes (mean=1.20x10-5). For example, the 
Peninsular Malaysia isolate P137 appears to have introgressed from the Mn-Pk cluster, and its 
partial similarity to the current NBPXa haplotypes of the Mn-Pk’s clade suggests it could also be 
a non-recent event. Finally, NBPXb gene had low diversity, with intra-cluster genetic distances 
being smaller than those found in the DBP genes. Several introgression events were identified, 
where 9 out of 33 (27%) of the Mn-Pk cluster isolates presented with Mf-Pk type haplotypes 
(Figure 4B, right; red stars). Most of these isolates clustered together and are separated from 
the Mf-Pk samples, which could be a reflection of a unique non-recent introgression event. The 
isolate KT233 positioned in the “Mn-Pk” group using all SNPs, has a much similar NBPXb 
haplotype to those found in the Mf-Pk samples, reflecting a more recent exchange event.  
 
DISCUSSION 
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The SWGA method produced reliable sequence data for parasite isolates obtained from 
unprocessed blood belonging to the three currently known subpopulations of P. knowlesi.  This 
method is cost-effective, does not require sample processing at the time of collection, requires 
low quantities of input DNA, and is easy to implement. Importantly, the approach permits the 
genomic analysis of isolates that would otherwise be impossible to investigate, as demonstrated 
by the poor WGS results of the non-SWGA DNA when compared with their respective SWGA 
samples. A neighbour-joining tree based on SNP data revealed 3 predominant clusters, 
consistent with recent findings, and the positioning of the SWGA isolates confirmed their origin. 
The 4 recent Peninsular Malaysia isolates clustered closely with the long-term maintained 
samples originating from different regions in Peninsular Malaysia and the Philippines.  Of the 16 
isolates originating from Sabah, Malaysia, 2 belonged to the Mn-Pk associated cluster, and 14 
belonged to the Mf-Pk associated cluster. This finding is consistent with the higher proportions 
of samples circulating in humans belonging to the Mf-Pk cluster 30 and confirms the presence of 
both Borneo monkey host-related subpopulations in Sabah.  
 
Previous population genetics studies on P. knowlesi subpopulations among human and macaque 
isolates from Malaysian Borneo provided evidence that chromosomal-segment exchanges 
between subpopulations have occurred recently 20. This observation could be indicative of 
subpopulations that diverged in isolation and have re-connected, possibly due to deforestation 
and disruption of wild macaque habitats. Up until now these introgressions had only been 
observed in parasites from Malaysian Borneo 10, but the inclusion of recent Peninsular Malaysia 
isolates allowed us to scan for more widespread events. We identified regions that presented 
evidence of introgression, in particular, with exceptionally high average SNP diversity when 
compared to the Peninsular isolates and exceptionally low diversity when compared to Mn-Pk 
or Mf-Pk isolates. This approach highlighted the presence of such events in 2 Peninsular samples, 
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where the identified regions were found to be introgressions from Mn-Pk type haplotypes and 
spanned several chromosomes. This work shows that genomic exchange events are more 
widespread than previously thought, and they also affect the geographic subpopulation of 
Peninsular Malaysia. This finding does not contradict the previously observed  distribution of P. 
knowlesi subpopulations, and is consistent with microsatellite analyses that have identified 
traces of Borneo-associated clusters in regions of Peninsular Malaysia 30,31. 
 
Regions identified with genomic exchange events were enriched with large multi-gene families 
coding for Plasmodium exported proteins and tryptophan-rich antigens, as well as loci 
associated with erythrocyte invasion in P. knowlesi. These findings contrast with our previous 
results found in previous studies in Borneo 20, where the genes involved in introgression events 
were enriched by mosquito-stage related genes and could suggest that there are different 
factors driving the exchanges between geographical regions. We found that all known RBL/DBP 
invasion genes (DBP ,  and ; NBP Xa and Xb) are highly differentiated and cluster the isolates 
into 3 subpopulations. It is known that both NBPXa and NBPXb bind to RBCs and NBPXa is known 
to be essential for the invasion of human RBCs, furthermore DBPα in P. knowlesi  is the adhesin 
binding the Duffy antigen/chemokine receptor (DARC) with the role of the two paralogues (DBP 
β and γ) still unclear. This clustering is consistent with host-related factors being one of the main 
drivers for their genetic differentiation; although the Peninsular subpopulation is assumed to be 
a geographic subdivision rather than a host-associated cluster. Across all five loci the Mf-Pk 
group is the most genetically diverse. The DBP and DBP did not present any genetic exchanged 
pattern. For the NBPXb gene the subpopulations were not as strongly differentiated as in other 
genes, and some Mn-Pk isolates (including from Sabah) presented with introgression from the 
Mf-Pk subpopulation. This introgression event could be related to the adaptation of the 
parasites to the different hosts, as it has been shown that the two Borneo subpopulations can 
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be found in both species of macaques 21,22,30. Furthermore, the events observed here could 
involve yet another subpopulation of Peninsular Mn-Pk type of P. knowlesi as the level of 
sampling currently is very low and the haplotypes do show a degree of differentiation with the 
other Mn-Pk haplotypes. Other genes such as DBP and NBPXa presented introgression events 
from Mn-Pk into the Peninsular subpopulation. NBPXa has the lowest level of genetic diversity, 
which suggests that this gene is highly conserved across subpopulations. This is an important 
finding because NBPXa is required for the invasion of human red blood cells (RBCs) in vitro 29  
and it has been shown that different haplotypes in DBP region II have different binding 
affinities to the DARC receptor in human RBCs 32. Therefore, these genetic exchanges affecting 
genes involved in invasion may reflect an adaptation to a new host and may confer improved 
binding and increase invasion efficiency. It will be important to investigate whether changes in 
the haplotypes of other genes involved in human RBC invasion affect the ability of the parasite 
to invade and multiply in human cells.  Genetic interactions between invasion genes may assist 
parasites with adapting more efficiently to humans and facilitate transmission, which could 
hamper malaria elimination efforts.  
 
Overall, by establishing an effective SWGA strategy for P. knowlesi, it will be possible to perform 
much needed large-scale WGS studies of the parasite genomic diversity across Asia, as well as 
investigate important fundamental biology such as the genetics underlying mechanisms 
involved red blood cell invasion.  
 
MATERIALS AND METHODS 
Sample collection and preparation 
For this project we use P. knowlesi DNA samples from Sabah in Malaysian Borneo (n=21) 
(provided by the Menzies School of Health Research) and from Peninsular Malaysia (n=5) 
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(provided by the University of Malaya).  Samples from Sabah were obtained from patients 
enrolled as part of clinical malaria studies conducted from 2010 to 2014 6,33. Ethical approval for 
these studies was obtained from the Ministry of Health, Malaysia, and Menzies School of Health 
Research, Australia. Samples from Peninsular Malaysia were collected from patients admitted 
to University Malaya Medical Centre (UMMC), Kuala Lumpur, from July 2008 to December 
201434. Ethics was approved by the University of Malaya Medical Centre Medical Ethics 
Committee (MEC Ref. No: 817.18).  All DNA samples were quantified using the Qubit 
Fluorometer using the dsDNA high sensitivity method (Invitrogen). Confirmation of P. knowlesi 
monoinfection was determined by PCR, as described previously 7.  The relative amount of 
parasite DNA and human DNA in each sample was determined using a qPCR protocol using 
primers and probes specific for each species 35–37. Pure human and P. knowlesi standards (10 
points) were included to determine the relative concentration (ng/ul) of each organism’s DNA 
in a sample.  
 
Primer design for selective whole genome amplification 
The swga program (www.github.com/eclarke/swga) was used to identify primer sets that 
preferentially amplify the P. knowlesi genome, providing as input the new A1-H.1 reference for 
the P. knowlesi human-adapted line A1-H.1 28 and the established human reference 
human_g1k_v37 (ftp://ftp.1000genomes.ebi.ac.uk). The 10 best sets consist of combinations of 
4 to 6 oligonucleotides each, with several overlapping primers and contained two that were 
present in all sets. The set with the lowest Gini index and perfectly even binding across the 
genome consists of the following 6 primers: 5’-ATAATC*G*T-3’, 5’-ATTATC*G*T-3’, 5’-
CGAAAT*A*G-3’, 5’-CGATAA*A*G-3’, 5’-GAATAA*C*G-3’ and 5’-TCGTAA*T*A-3’; where 
asterisks represent phosphorothioate bonds to prevent primer degradation by the exonuclease 
activity of the Phi29 polymerase  
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Selective whole genome amplification 
Selective whole genome amplification (SWGA) was performed according to the published 
protocols 24. All SWGA reactions were carried out in the UV Cabinet for PCR Operations (UV-B-
AR, Grant-Bio) to minimize contamination. SWGA reactions were performed containing a 
maximum of 50ng of total input genomic DNA (and a minimum of 5ng), 5µl of 10x Phi29 DNA 
Polymerase Reaction Buffer (New England BioLabs), 0.5µl of Purified 100x BSA (New England 
BioLabs), 0.5µl of 250µM Primer mix of Pkset1, 5µl 10mM dNTP (Roche), 30 units Phi29 DNA 
Polymerase (New England BioLabs) and Nuclease-Free Water (Ambion, The RNA Company) to 
reach a final reaction volume of 50µl. The reaction was carried out on a thermocycler with the 
following step-down program: 5 minutes at 35°C, 10 minutes at 34°C, 15 minutes at 33°C, 20 
minutes at 32°C, 25 min 31°C, 16 hours at 30°C and 10 minutes at 65°C. The SWGA samples were 
diluted 1:1 with EB buffer (Qiagen) and the reaction was purified using the AMPure XP beads 
(Beckman-Coulter), using a sample to beads ratio of 1:1 according to the protocol. 
 
Whole-genome sequencing, bioinformatics analysis and population genetics 
The SWGA products and unamplified DNA were sequenced on an Illumina MiSeq or HiSeq4000. 
DNA and SWGA Libraries for MiSeq were prepared using the QIAseq FX DNA Library Kit (Qiagen) 
as per manufacturer’s instructions. A 20-minute fragmentation step was optimized for 
Plasmodium samples. For HiSeq runs, libraries were prepared using the NEB Next Ultra DNA 
Library Prep Kit for Illumina (from New England BioLabs Inc., E7370).  All samples were run using 
150 bp paired-end reads. The raw sequence data for the isolates was aligned against the new 
reference for the human-adapted line A1-H.1 (no regions were excluded for analysis)28 using 
bwa-mem software 38.  WGS data from an extra 156 publicly available samples were also used 
for analysis (sourced from 21,22,39, where sequencing accession numbers are listed).  SNPs were 
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called using the Samtools software suite 40, and those of high quality were retained using 
previously described methods20. Samples with high levels of multiplicity of infection (detecting 
using estMOI 41) or statistical outliers established using a principal component analysis (PCA) 
were removed. For comparisons between populations, we applied the PCA and neighbour-
joining tree clustering approaches using a matrix of pairwise identity by state values calculated 
from the SNPs. Nucleotide diversity () was calculated using in-house R scripts. R-base scripts 
were used to calculate linear regressions for the SNP  plots. 
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Table 1  
Comparison of whole genome sequencing before and after parasite enrichment using SWGA 
(Table on next page) 
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Sample ID 
Parasitemia 
p/µl* (%) 
Sample 
type 
Reads aligned 
to P. knowlesi 
reference 
(%)* 
% genome 
with 
coverage>5 
% genes 
with 
coverage>5 
% intergenic 
regions with 
coverage>5 
Mean 
coverage 
Total N 
SNPs 
1 
320 
(0.006%) 
No 
SWGA 
2.45 0.64 0.80 0.52 1.71 
                   
1,797  
SWGA 12.11 19.08 23.36 16.51 11.94 
                 
59,031  
2 
539 
(0.01%) 
No 
SWGA 
0.81 0.04 0.03 0.04 1.28 
                        
15  
SWGA 3.66 6.49 7.54 5.97 4.38 
                 
14,746  
3 
851 
(0.017%) 
No 
SWGA 
3.15 3.88 4.69 3.34 2.25 
                 
11,974  
SWGA 27.95 43.32 53.40 37.14 17.52 
               
143,483  
4 
1581 
(0.03%) 
No 
SWGA 
1.14 0.08 0.08 0.09 1.34 
                      
127  
SWGA 20.37 11.79 14.59 10.05 8.96 
                 
34,314  
5 
3554 
(0.07%) 
No 
SWGA 
1.22 0.32 0.35 0.30 1.58 
                      
628  
SWGA 6.31 28.01 35.21 23.32 6.51 
                 
79,139  
6 
5300 
(0.1%) 
No 
SWGA 
2.31 3.38 4.34 2.66 2.18 
                 
10,479  
SWGA 17.10 48.26 59.66 41.19 15.71 
               
159,652  
7 
5875 
(0.11%) 
No 
SWGA 
1.87 0.28 0.31 0.26 1.55 
                      
609  
SWGA 20.26 54.74 66.95 47.41 18.72 
               
179,304  
8 
10634 
(0.2%) 
No 
SWGA 
2.34 2.67 3.55 2.00 2.10 
                   
8,147  
SWGA 22.33 60.50 73.96 52.40 23.61 
               
208,202  
9 ND 
No 
SWGA 
10.59 2.51 2.58 2.56 2.14 
                   
2,197  
SWGA 44.54 32.03 38.01 28.87 8.97 
               
119,157  
10 
26368 
(0.5%) 
No 
SWGA 
11.01 31.36 36.22 28.77 4.05 
               
104,805  
SWGA 42.21 48.26 59.89 40.99 18.04 
               
162,920  
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*These results are from single runs, and not pooled samples (average of a total of 2 billion bp 
sequenced per sample (human and parasite)). 
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FIGURES 
Figure 1 
Correlation of parasitaemia (%) and genome coverage (> 5 reads) in amplified DNA samples.  
Parasitaemia data was available for 13 amplified samples used in this study. An increase in 
coverage is observed with samples with higher parasitaemias (R-squared = 0.6). 
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Figure 2 
Neighbour-Joining tree for 103 P. knowlesi isolates shows expected grouping into three 
clusters.  
The tree shows the expected split into three different clusters associated with: (i) Peninsular 
Malaysia (purple in tips), (ii) Malaysian Borneo Macaca nemestrina (Mn-Pk, green) and (iii) 
Malaysian Borneo M. fascicularis (Mf-Pk, blue). The tree also shows the correct positioning of 
the 4 newly generated Peninsular isolates (in red) within the Peninsular cluster, and the 
clustering of the 16 new Malaysian Borneo isolates from Sabah (in orange) within either of the 
Mf-Pk or Mn-Pk associated clusters. 
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Figure 3 
P. knowlesi isolates from Peninsular Malaysia (P137 and P050) present introgression events 
from Mn-Pk sub-population.  Peninsular isolate P137 was compared to DIM5 (top two panels) 
as a representative of the Mn-Pk cluster, and DIM6 (second row panels) of the Mf-Pk cluster. 
Isolate P050 was compared to the same isolates in the bottom 4 panels. On the top most left 
panel each green dot represents a 50 kbp section of the DIM5 genome. Its position on the X-axis 
is defined by the average SNP π obtained by comparing its sequence in a pairwise manner to the 
same genome fragment in each isolate in the Mn-Pk cluster, and in the Y-axis the average SNP 
π is compared to the same fragment of the Peninsular isolates. This average SNP π defines the 
similarity of each dot to the different clusters. The top most right panel represents the same 
data as the top left most panel with the P137 50Kb fragments highlighted in purple for clarity. 
The same analysis was conducted in the second row of panels but using an Mf-Pk cluster isolate 
and using the average SNP π to Mf-Pk as the X-axis. The dashed line represents the linear 
regression for the coloured dots in each plot, and the regions of interest were identified (in light 
green in the right panels) by finding the fragments of the Peninsular isolate genomes that 
presented low similarity to the Peninsular cluster and high similarity to either the Mn-Pk (green) 
or Mf-Pk (blue). This approach accounts for the highest residuals. After further filtering by 
exploration of individual genes, the results were reported in Supplementary Table 2. 
 
(Figure on next page) 
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Figure 4 
Haplotype plot and neighbour-joining tree for 5 invasion genes ((A) DBPα, (B) NBPXb, (C) 
DBPβ, (D) DBPγ and (E) NBPXa) provides insight into population dynamics of the different 
haplotypes. A strong genetic divergence of the sequences from the different clusters was found 
for each of the 5 genes and the Peninsular cluster presented the highest diversity in all 5 genes 
(A-E). In the case of DBPα (A, right) and DBPβ (C, right) gene sequences clustered in concordance 
with the whole genome pattern. In the case of DBPγ (D, right), the sample P050 showed clear 
evidence of having been introgressed from the Mn-Pk cluster (green, highlighted with a red star). 
This can also be confirmed by the partial similarity of the haplotype for sample P050 with the 
Mn-Pk (D, left). For the NBPXa gene (E), an introgression event can be seen from Mn-Pk cluster 
for the isolate P137. The NBPXb gene (B, right) presented a fairly distinct pattern of diversity. 
The clusters have a small genetic distance between themselves, making the separation between 
them less obvious and 9 out of 33 (27%) of the Mn-Pk cluster isolates presented with Mf-Pk type 
haplotypes (highlighted with red stars). 
(Figure on pages 123 [A and B], 124 [C and D] and 125 [E]) 
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Supplementary table 1 
The samples analysed 
 
Sample Code Area estMOI** Group* 
ERR274221 DIM1 Sarikei 0.8 Mf-Pk 
ERR274222 DIM2 Sarikei 0.7 Mf-Pk 
ERR274224 DIM3 Sarikei 0.6 Mn-Pk 
ERR274225 DIM4 Sarikei 0.5 Mn-Pk 
ERR366425 DIM5 Sarikei 0.3 Mn-Pk 
ERR366426 DIM6 Sarikei 0.2 Mf-Pk 
ERR985372 BTG1000 Betong 0.8 Mf-Pk 
ERR985373 BTG123 Betong 0.7 Mf-Pk 
ERR985374 BTG26 Betong 1.6 Mf-Pk 
ERR985375 BTG35 Betong 6.8 Mf-Pk 
ERR985376 BTG39 Betong 9.9 Mf-Pk 
ERR985377 BTG42 Betong 1.0 Mf-Pk 
ERR985378 BTG46 Betong 1.5 Mf-Pk 
ERR985379 BTG47 Betong 1.2 Mf-Pk 
ERR985380 BTG49 Betong 5.9 Mf-Pk 
ERR985381 BTG50 Betong 1.4 Mf-Pk 
ERR985382 BTG53 Betong 1.3 Mf-Pk 
ERR985383 BTG55 Betong 3.6 Mf-Pk 
ERR985384 BTG62 Betong 3.0 Mf-Pk 
ERR985385 CDK88 Kapit 1.1 Mf-Pk 
ERR985386 KT03 Kapit 22.8 Mf-Pk 
ERR985387 KT04 Kapit 2.7 Mf-Pk 
ERR985388 KT06 Kapit 1.0 Mf-Pk 
ERR985389 KT100 Kapit 2.8 Mf-Pk 
ERR985390 KT103 Kapit 0.5 Mf-Pk 
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ERR985391 KT107 Kapit 0.6 Mf-Pk 
ERR985392 KT109 Kapit 0.6 Mf-Pk 
ERR985393 KT120 Kapit 0.5 Mf-Pk 
ERR985394 KT12 Kapit 1.0 Mf-Pk 
ERR985395 KT26 Kapit 50.4 Mf-Pk 
ERR985396 KT29 Kapit 21.0 Mf-Pk 
ERR985397 KT30 Kapit 22.3 Mf-Pk 
ERR985398 KT34 Kapit 1.2 Mf-Pk 
ERR985399 KT40 Kapit 1.3 Mf-Pk 
ERR985400 KT48 Kapit 1.0 Mf-Pk 
ERR985401 KT50 Kapit 1.0 Mf-Pk 
ERR985402 KT57 Kapit 0.7 Mf-Pk 
ERR985403 KT72 Kapit 0.6 Mf-Pk 
ERR985404 KT73 Kapit 1.2 Mf-Pk 
ERR985405 KT77 Kapit 30.9 Mf-Pk 
ERR985406 KT81 Kapit 0.5 Mf-Pk 
ERR985407 KT92 Kapit 0.8 Mf-Pk 
ERR985408 KT94 Kapit 0.6 Mf-Pk 
ERR985409 KT95 Kapit 3.5 Mf-Pk 
ERR985410 BTG44 Betong 32.7 Mn-Pk 
ERR985411 BTG63 Betong 0.8 Mn-Pk 
ERR985412 CDK206 Kapit 0.8 Mn-Pk 
ERR985413 KT114 Kapit 0.5 Mn-Pk 
ERR985414 KT25 Kapit 0.8 Mn-Pk 
ERR985415 KT27 Kapit 0.9 Mn-Pk 
ERR985416 KT31 Kapit 1.2 Mn-Pk 
ERR985417 KT42 Kapit 29.9 Mn-Pk 
ERR985418 KT55 Kapit 0.7 Mn-Pk 
ERR985419 KT56 Kapit 4.5 Mn-Pk 
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PKAP_KK41 SKK41 Sabah 0.3 Mf-Pk 
PKAP_KK48 SKK48 Sabah 3.0 Mf-Pk 
PKAP_MK34 SMK34 Sabah 0.8 Mf-Pk 
PKAP_QEM265 SEM265 Sabah 0.0 Mf-Pk 
PKAP_QEM639 SEM639 Sabah 9.0 Mf-Pk 
PKAP_QEM687 SEM687 Sabah 0.6 Mn-Pk 
PKAS04_com SAS04 Sabah 0.0 Mf-Pk 
PKAS05_com SAS05 Sabah 1.8 Mf-Pk 
PKAS07_com SAS07 Sabah 7.5 Mf-Pk 
PKAS08_com SAS08 Sabah 0.3 Mf-Pk 
PKAS09_com SAS09 Sabah 0.5 Mn-Pk 
PKAS10_com SAS10 Sabah 0.6 Mf-Pk 
PKAS11_com SAS11 Sabah 0.5 Mf-Pk 
PKAS12_com SAS12 Sabah 0.3 Mf-Pk 
PKAS13_com SAS13 Sabah 18.0 Mf-Pk 
PKAS14_com SAS14 Sabah 0.5 Mf-Pk 
PKAS15_com SAS15 Sabah 20.9 Mf-Pk 
PKAS16_com SAS16 Sabah 0.5 Mf-Pk 
SRR2221468 Hackeri Clinic 1.2 Peninsular 
SRR2222335 H(AW) Clinic 0.0 Peninsular 
SRR2225467 Malayan Clinic 10.7 Peninsular 
SRR2225571 MR4-H Clinic 0.6 Peninsular 
SRR2225573 Philippine Clinic 0.8 Peninsular 
SRR3135172 YH1 Clinic 5.6 Peninsular 
swga002d P002 Peninsular 0.8 Peninsular 
swga004 P004 Peninsular 3.2 Peninsular 
ERR2214837 KT133 Kapit 0.3 Mn-Pk 
ERR2214838 KT143 Kapit 0.2 Mn-Pk 
ERR2214839 KT147 Kapit 0.3 Mn-Pk 
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ERR2214840 KT151 Kapit 0.3 Mn-Pk 
ERR2214841 KT161 Kapit 0.3 Mn-Pk 
ERR2214842 KT165 Kapit 14.6 Mn-Pk 
ERR2214843 KT172 Kapit 0.2 Mn-Pk 
ERR2214844 KT176 Kapit 0.3 Mn-Pk 
ERR2214845 KT186 Kapit 1.0 Mn-Pk 
ERR2214846 KT198 Kapit 0.3 Mn-Pk 
ERR2214847 KT217 Kapit 0.4 Mn-Pk 
ERR2214848 KT221 Kapit 0.2 Mn-Pk 
ERR2214849 KT223 Kapit 0.3 Mn-Pk 
ERR2214850 KT224 Kapit 19.0 Mn-Pk 
ERR2214851 KT226 Kapit 0.6 Mn-Pk 
ERR2214852 KT231 Kapit 0.2 Mn-Pk 
ERR2214853 KT233 Kapit 0.2 Mn-Pk 
ERR2214854 KT243 Kapit 0.4 Mn-Pk 
ERR2214855 KT263 Kapit 0.4 Mn-Pk 
ERR2214856 KT266 Kapit 13.6 Mn-Pk 
ERR2214857 KT305 Kapit 0.7 Mn-Pk 
swga_0137_f P137 Peninsular 0.4 Peninsular 
swga_050_f P050 Peninsular 0.1 Peninsular 
* Borneo Malaysia (M. nemestrina (Mn-Pk) and M. fascicularis (Mf-Pk) macaques and humans) 
** Percentage of the genome that shows evidence of MOI >1 based on estMOI software 41 
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Supplementary table 2 
Genetic regions with evidence of introgression* for the P050 and P137 samples 
Chr Start End Samples Genes affected 
1 1 50000 P050, P137 PKNH_0100500 (hypothetical protein, conserved), 
PKNH_0100600 (CPPUF**), PKNH_0100700 (CPPUF) 
2 750000 787646 P050 PKNH_0211700 (CPPUF), PKNH_0211800 (NFS), PKNH_0211900 
(DNMT) 
7 1 50000 P050 PKNH_0700700 (CPPUF), PKNH_0700800 (RER1), PKNH_0700900 
(RAB7) 
7 1250000 1300000 P137 PKNH_0728200 (CPPUF), PKNH_0728300 (CPPUF), 
PKNH_0728400 (CPPUF), PKNH_0728800 (MSP1P), 
PKNH_0728900 (MSP1), PKNH_0729000 (CPPUF), PKNH_0729100 
(diacylglycerol kinase, putative), PKNH_0729200 (CYP72), 
PKNH_0729300 (CPPUF) 
7 1450000 1500000 P050, P137 PKNH_0734500 (PEPUF***), PKNH_0734600 (CPPUF), 
PKNH_0734700 (ETRAMP), PKNH_0734800 (Plasmodium 
exported protei, PHIST), PKNH_0734900 (PEPUF), PKNH_0735000 
(lysophospholipase, putative) 
9 1 50000 P137 PKNH_0900100 (hypothetical protein), PKNH_0900200 (PEPUF), 
PKNH_0900300 (hypothetical protein) 
9 50000 100000 P050, P137 PKNH_0900400 (hypothetical protein), PKNH_0900500 (PEPUF), 
PKNH_0900600 (CPPUF) 
10 1450000 1500000 P137 PKNH_1032400 (SBP1), PKNH_1032500 (tryptophan-rich antigen, 
putative), PKNH_1032600 (PEPUF), PKNH_1032800 (PEPUF) 
11 2300000 2350000 P050, P137 PKNH_1149000 (CPPUF), PKNH_1149100 (PEPUF), 
PKNH_1149200 (PEPUF), PKNH_1149400 (PEPUF), 
PKNH_1149600 (hypothetical protein) 
12 2050000 2100000 P050, P137 PKNH_1246200 (CPPUF), PKNH_1246500 (PEPUF), 
PKNH_1246600 (PEPUF) 
12 2100000 2150000 P050, P137 PKNH_1246800 (PEPUF), PKNH_1246900 (PEPUF), 
PKNH_1247000 (PEPUF) 
12 2150000 2200000 P050 PKNH_1247800 (PEPUF), PKNH_1247900 (CPPUF) 
13 1 50000 P050, P137 PKNH_1300400 (Plasmodium exported protein, PHIST), 
PKNH_1300500 (tryptophan-rich antigen, putative), 
PKNH_1300600 (tryptophan-rich antigen, putative), 
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PKNH_1300700 (tryptophan/threonine-rich antigen, putative), 
PKNH_1300900 (PEPUF) 
13 50000 100000 P050, P137 PKNH_1301000 (tryptophan-rich antigen, putative), 
PKNH_1301100 (lysophospholipase, putative), PKNH_1301300 
(PPUF), PKNH_1301800 (CPPUF), PKNH_1302100 (mitochondrial 
phosphate carrier protein, putative) 
13 1200000 1250000 P050, P137 PKNH_1325500 (CPPUF), PKNH_1325600 (PEPUF), 
PKNH_1325700 (KAHRP), PKNH_1325800 (PEPUF), 
PKNH_1325900 (PEPUF), PKNH_1326000 (Plasmodium exported 
protein, PHIST), PKNH_1326100 (PEPUF), PKNH_1326200 (PEPUF) 
14 1 50000 P050 PKNH_1400800 (DBPbeta), PKNH_1401000 (PEPUF) 
14 50000 100000 P050 PKNH_1401100 (PEPUF), PKNH_1401200 (PEPUF), 
PKNH_1401300 (cytoadherence linked asexual protein, putative), 
PKNH_1401400 (PEPUF), PKNH_1401500 (lysophospholipase, 
putative), PKNH_1401600 (PEPUF), PKNH_1401800 (PEPUF), 
PKNH_1401900 (CPPUF), PKNH_1402000 (PPUF), PKNH_1402100 
(PEPUF) 
14 100000 150000 P050 PKNH_1402200 (PEPUF), PKNH_1402300 (GAP), PKNH_1402400 
(ETRAMP), PKNH_1402500 (hypothetical protein), 
PKNH_1402600 (CPMPUF****) 
14 800000 850000 P137 PKNH_1417800 (MCM4), PKNH_1417900 (ApiAP2) 
14 3150000 3200000 P050, P137 PKNH_1472100 (RON3), PKNH_1472200 (CPPUF), PKNH_1472300 
(NBPXa) 
14 3200000 3250000 P137 PKNH_1472400 (tryptophan-rich antigen, putative), 
PKNH_1472600 (PEPUF), PKNH_1472700 (PEPUF), 
PKNH_1472800 (Plasmodium exported protei, PHIST), 
PKNH_1472900 (PEPUF) 
* Cluster Origin of Introgression is Mn-Pk; ** CPPUF: Conserved Plasmodium protein, unknown 
function; *** PEPUF: Plasmodium exported protein, unknown function; **** CPMPUF: 
Conserved Plasmodium membrane protein, unknown function  
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Supplementary figure 1 
Estimation of multiplicity of infection (MOI) identifies isolates presenting clear evidence of 
presenting several clones.  
MOI was assessed using overall number of heterozygous calls, as well as the fraction of genome 
supporting multiplicity >1 obtained using estMOI software 41. This data supports the ability of 
the SWGA to identify mixed infections and suggests a non-bias towards a specific clone, as 
samples SAS15 and SAS13 were SWGA amplified and yet have been classified as presenting MOI 
>1 by both methods. 
 
 
Pen = Peninsular; Borneo Malaysia (M. nemestrina (Mn-Pk) and M. fascicularis (Mf-Pk) 
macaques and humans) 
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SUPPLEMENTARY MATERIAL 
S1 figure 
Phylogenetic tree for P. falciparum laboratory strains constructed using the var2csa 
alignments reveals two near identical gene copies for HB3 and distinct copies for D10 and 
KH01. Two sequences of each HB3 copy were obtained from two different PacBio runs and 
were found to be identical, highlighting the robustness of the approach. No significant 
clustering by geography was found for other samples, as expected from the patterns shown 
by the short read data. 
 
D10 (Papua New Guinea), T9/96 (Thailand), HB3 (Honduras), K1 (Thailand), and NF54 (3D7 
Parental line), GN01 (Guinea), CD01 (Congo), Dd2 (IndoChina), KE01 (Kenya), KH01 and KH02 
(Cambodia), GA01 (Gabon), IT (Brazil), SD01 (Sudan), TG01 (Togo), SN01 (Senegal) and ML01 
(Mali); samples with extra copies are colour coded. 
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S2 figure 
Summary of the analytical and bioinformatics pipelines used 
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S3 figure 
The filtered P. falciparum isolates based on MOI and heterozygous calls* (n=2,099; with 
>70% of their genome with multiplicity of infection of 1 and <1.5% of heterozygous SNP calls)  
 
*All samples have >30-fold genome-wide coverage 
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S4 figure 
Estimating copy number in the var2csa gene using coverage in 4 P. falciparum laboratory strains for which Paired End data was available, (no D10 paired 
end data available). Red line indicates the chromosome average, and the dashed line represents the average coverage in the long exon 2 of the var2csa 
gene. Gene boundaries are in clue vertical lines, and intron boundaries are represented by green vertical lines in each plot. 
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S5 figure 
Var2csa copy number distributions in P. falciparum and mixed SNP calls across the samples, including 
5 laboratory strains with Illumina data available. A clear trend of increased mixed calls (y-axis) is found 
when extra copies of the gene are identified using coverage fold increase (x-axis).  
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S6 figure 
The multiplicity of infection (MOI*) 32 in the genome and the proportion of mixed calls in the 
var2csa gene in P. falciparum. Samples sorted based on proportion of mixed calls in the var2csa  gene 
(red axis). A decrease in the average percentage of genome supporting MOI of 1 is observed for 
isolates with increased proportion of mixed calls in the var2csa gene. Supporting the presence of 
mixed calls in the gene due to MOI >1 rather than by extra copies of the gene. The threshold used for 
downstream de-novo assembly was 5% of mixed calls/total number of calls. 
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S7 figure 
Near perfect matching of the assembled P. falciparum strain var2csa sequences from our pipeline 
compared to the long-read gold standard. Dot plot comparing the Illumina assembly for each 
laboratory strain and its PacBio generated sequence. 
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S8 figure 
Distribution of the lengths of the different DBL domains in the var2csa gene of P. falciparum across 
the field samples reveals increased length distribution for DBL2X domain (n=1,249). A wider range 
can be found in the distribution of the lengths for the DBL2X domain of the var2csa gene of the 
isolates compared to the other DBL domains. This a result of the presence of multiple rare insertions 
and deletions in this region. 
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S9 figure 
Global map of the distribution of the four clades based on the ID1-DBL2Xb region of the var2csa gene in Plasmodium falciparum 
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S10 figure 
A rarefaction curve analysis of the haplotype diversity in the ID1-DBL2Xb region of the var2csa 
gene in Plasmodium falciparum (A; country, B; region) reveals higher diversity in African 
populations compared to South East Asian populations, which is supported by the neighbourhood 
joining trees for these regions across geography (C, D, E)  
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S1 table 
Distribution of P. falciparum isolates with extra copies of the var2csa gene per country 
  Total Single copy Multiple Copies 
Country n n % n % 
Burkina Faso 27 14 51.9 13 48.1 
Cameroon 80 58 72.5 22 27.5 
Gambia 47 35 74.5 12 25.5 
Ghana 222 138 62.2 84 37.8 
Guinea 78 51 65.4 27 34.6 
Mali 29 17 58.6 12 41.4 
Nigeria 6 4 66.7 2 33.3 
West Africa 489 317 64.8 172 35.2 
DRC 136 96 70.6 40 29.4 
Kenya 26 18 69.2 8 30.8 
Malawi 182 123 67.6 59 32.4 
Tanzania 43 36 83.7 7 16.3 
Uganda 5 4 80.0 1 20.0 
Madagascar 17 12 70.6 5 29.4 
East Africa 409 289 70.7 120 29.3 
Bangladesh 36 18 50.0 18 50.0 
Cambodia 492 428 87.0 64 13.0 
Laos 88 50 56.8 38 43.2 
Myanmar 109 89 81.7 20 18.3 
Thailand 264 208 78.8 56 21.2 
Vietnam 155 98 63.2 57 36.8 
South East Asia 1108 873 78.8 235 21.2 
PNG (Oceania) 24 3 12.5 21 87.5 
Brazil 9 9 100.0 0 0.0 
Colombia 15 14 93.3 1 6.7 
Peru 9 9 100.0 0 0.0 
South America 33 32 97.0 1 3.0 
Overall 2099 1532 73.0 567 27.0 
DRC Democratic Republic of Congo; PNG Papua New Guinea 
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S2 table 
The frequency of the different protein sequence clades based on the ID1-DBL2Xb region of the 
var2csa genes in P. falciparum, across countries (n=1,373) 
  Clade 1 (3D7-like) Clade 2 (FCR3-like) Clade 3 Clade 4 
Country n % n % n % N % 
Burkina Faso 7 100.0 0 0.0 0 0.0 0 0.0 
Cameroon 7 100.0 0 0.0 0 0.0 0 0.0 
Gambia 15 48.4 11 35.5 3 9.7 2 6.5 
Ghana 48 41.7 44 38.3 1 0.9 22 19.1 
Guinea 11 33.3 12 36.4 0 0.0 10 30.3 
Mali 6 40.0 5 33.3 2 13.3 2 13.3 
Nigeria 0 0.0 1 33.3 0 0.0 2 66.7 
West Africa 94 44.5 73 34.6 6 2.8 38 18.0 
DRC 27 35.5 33 43.4 0 0.0 16 21.1 
Kenya 10 47.6 9 42.9 0 0.0 2 9.5 
Malawi 20 21.1 49 51.6 3 3.2 23 24.2 
Malawi* 13 44.8 6 20.7 1 3.4 9 31.0 
Malawi & Benin** 74 52.1 59 41.5 2 1.4 7 4.9 
Tanzania 9 30.0 11 36.7 0 0.0 10 33.3 
Uganda 2 50.0 2 50.0 0 0.0 0 0.0 
Madagascar 3 30.0 3 30.0 0 0.0 4 40.0 
East Africa 158 38.8 172 42.3 6 1.5 71 17.4 
Bangladesh 1 8.3 9 75.0 0 0.0 2 16.7 
Cambodia 76 21.1 266 73.9 0 0.0 18 5.0 
Laos 8 20.0 30 75.0 0 0.0 2 5.0 
Myanmar 14 19.4 55 76.4 0 0.0 3 4.2 
Thailand 54 29.7 118 64.8 0 0.0 10 5.5 
Vietnam 18 26.5 42 61.8 0 0.0 8 11.8 
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South East Asia 170 23.5 511 70.8 0 0 41 5.7 
PNG 0 0.0 1 50.0 0 0.0 1 50.0 
Brazil 0 0.0 0 0.0 0 0.0 3 100.0 
Colombia 4 40.0 5 50.0 0 0.0 1 10.0 
Peru 0 0.0 0 0.0 0 0.0 6 100.0 
South America 4 21.1 5 26.3 0 0.0 10 52.6 
Overall 427 31.1 771 56.2 12 0.9 163 11.9 
*Dara et al. 2017; ** Patel el at 2017 (n=124); DRC Democratic Republic of Congo; PNG Papua New 
Guinea; Bolded denotes African Populations and Shaded denotes South East Asian Populations 
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S3 table 
Diversity statistics by country in the open reading frame region (359 bp) upstream of the var2csa 
gene in 1,245 P. falciparum isolates 
Population n 
No. 
of Haplotypes 
Haplotype 
diversity 
(Hd) 
Nucleotide 
Diversity 
(𝝿) 
Average 
no. of 
nucleotide 
differences 
No. 
variable 
sites 
(n=360) 
Cameroon 46 28 0.974 0.020 7.21 31 
Gambia 27 14 0.940 0.020 7.35 26 
Ghana 111 53 0.973 0.021 7.42 38 
Guinea 38 21 0.929 0.020 7.37 32 
Mali 12 10 0.970 0.013 4.52 12 
DRC 75 48 0.98 0.025 9.00 35 
Kenya 16 12 0.958 0.017 6.26 19 
Malawi 103 42 0.970 0.024 8.65 38 
Tanzania 30 20 0.966 0.018 6.57 31 
Madagascar 10 8 0.956 0.017 6.20 15 
Bangladesh 12 10 0.970 0.031 11.11 30 
Cambodia 365 20 0.851 0.021 7.71 33 
Laos 42 18 0.911 0.030 10.76 37 
Myanmar 71 17 0.833 0.020 7.08 29 
Thailand 180 30 0.934 0.028 10.05 40 
Vietnam 72 23 0.867 0.025 8.89 38 
Colombia 10 5 0.822 0.016 5.78 16 
Overall 1245 163 0.952 0.025 8.86 50 
Bolded denotes African countries and shaded denotes South East Asian countries; DRC Democratic 
Republic of Congo 
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Supplementary Information 
 
Supplementary Figure 1: Structural variants located around the MDR1 gene (chromosome 
10) in the Thailand population; (i) a sample without a copy number variant or deletion (even 
coverage), (ii) a major deletion in the promoter region of the gene (n = 7); (iii) duplication of 
~35kb (position 351kbp to 389kbp, n = 1); and (iv) a combination of both structural variants 
(ii) and (iii), including two copies, one with the deletion in the promoter and another copy 
with a complete promoter (n = 4, Thailand). The horizontal dashed line is average 
chromosomal coverage and the red outline encloses the promoter region of the MDR1 
gene. 
 
Supplementary Figure 2: Intra-population evidence of directional selective pressure (iHS*) 
a) Thailand b) South America. * iHS integrated haplotype score; see Table 1 and Table 2 for a 
summary of the hits. 
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Supplementary figure 3: Principal component analysis based on 225k SNPs reveals strong 
clustering of isolates by continent. 
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Supplementary Figure 4: Identifying regions under directional selective pressure between 
Thailand and South America. 
Blue line: |Rsb| > 3 (P<0.003); Red line represents a human GWAS cut-off; see Table 4for a 
summary of the hits. 
 
Supplementary Figure 5: Principal component analysis based on the previously 
characterised 42 barcoding SNPs* does not reveal strong population clustering. 
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* SNPs and genotypes are shown in S4 Table
 
Supplementary Figure 6: Signatures of a mixed species infection based on heterozygous 
calls in mitochondrial markers (positions: 3,736–3,935bp). 
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Supplementary Table 1: The 46 study isolates 
Country Sample 
Mean 
coverage 
SNPs 
Cambodia* SRR572648 359.4 29,791 
Cambodia SRR572649 1082.4 29,490 
Thailand ERR111710 59.8 29,326 
Thailand* ERR111711 121.2 30,494 
Thailand* ERR111712 93.0 31,933 
Thailand* ERR111713 86.7 29,977 
Thailand ERR111714 107.5 29,945 
Thailand* ERR111715 81.0 29,632 
Thailand* ERR111717 34.5 37,674 
Thailand ERR111718 94.2 30,324 
Thailand ERR111719 91.1 29,856 
Thailand* ERR111721 30.5 28,280 
Thailand ERR111722 50.2 29,370 
Thailand* ERR111723 42.1 31,034 
Thailand ERR111724 59.9 30,278 
Thailand ERR111725 62.8 29,966 
Thailand ERR111727 78.1 29,672 
Thailand* ERR111728 55.7 29,773 
Thailand* ERR111729 22.7 28,504 
Thailand ERR111730 86.0 30,105 
Thailand ERR111732 75.1 30,054 
Thailand* SRR1027921 63.0 30,600 
Thailand SRR1027922 104.9 30,180 
Thailand* SRR1027923 60.7 28,949 
North Korea SRS258286 2084.2 27,722 
Brazil I SRS258178 1173.8 23,100 
Belem SRR575087 629.0 22,491 
Sal-I SRR575089 31.5 108 
Peru Mdio SRR1798620 25.7 13,151 
Peru Mdio SRR1798621 32.8 14,580 
Peru SRS113792 33.0 14,675 
Colombia Tierralta* SRR2413274 14.9 13,367 
Colombia Tierralta* SRR2413275 24.2 19,812 
Colombia Tierralta* SRR2413304 37.0 21,339 
Colombia Tierralta* SRR2413306 48.6 20,973 
Colombia Tierralta* SRR2413357 15.2 15,559 
Mauritania SRS258091 1703.9 28,922 
Madagascar* SRR570031 456.6 28,077 
Madagascar* SRR828416 330.7 28,597 
Papua New Guinea* SRR828528 54.2 36,630 
Papua New Guinea ERR034096 136.8 30,097 
Papua New Guinea ERR034097 62.1 29,339 
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Papua New Guinea ERR054084 14.6 18,760 
Papua New Guinea* ERR054085 54.9 30,004 
India (Mumbai) ERR054087 21.4 25,098 
India VII SRS258349 501.0 28,035 
* evidence of polyclonality using the estMOI method [24] 
 
Supplementary Table 2: The SNPs 
Genome Size (bp) Total 
SNPs 
Non-
Coding 
Coding Non-
Syn. 
Syn. Intronic 
Nuclear 22,621,100 219,288 107,687 
(49%) 
111,601 
(51%) 
56,916 
(51%) 
35,812 
(32%) 
18,873 
(17%) 
Apicoplast 29,093 176 53 (30%) 123 
(70%) 
53 
(43%) 
70 
(57%) 
0 
(0%) 
Mito. 5,990 23 16 (70%) 7 
(30%) 
6 (86%) 1 (14%) 0 
(0%) 
Total 22,656,183 219,487 107,756 
(49%) 
111,731 
(51%) 
56,975 
(51%) 
35,883 
(32%) 
18,873 
(17%) 
Syn. Synonymous 
 
Supplementary Table 3: Non-synonymous mutations in candidate genes 
Gene Chr. Position Ref Alt Coding Change 
Thailand 
(n=22) 
S.America 
(n=11) 
Others 
(n=13) 
GTPCH 14 1825110 G C L38F 3 0 0 
GTPCH 14 1825322 G A G109D 1 1 0 
GTPCH 14 1825574 G T R193I 2 0 0 
GTPCH 14 1825654 G A E220K 1 1 0 
GTPCH 14 1826170 G A G392S 1 1 0 
GTPCH 14 1826180 C G A395G 2 0 0 
GTPCH 14 1826216 C T A407V 2 0 0 
DHFR 5 964758 T C,A F57L,F57I 18 0 2 
DHFR 5 964760 C A F57L 18 0 0 
DHFR 5 964761 A C S58R 0 3 0 
DHFR 5 964763 C A,G S58R,S58R 22 7 10 
DHFR 5 964771 C T T61M 18 0 2 
DHFR 5 964939 G C,A S117T,S117N 22 10 9 
DHFR 5 965106 A C I173L 0 2 0 
DHPS 14 1257156 A G M616T 0 0 2 
DHPS 14 1257346 G C P553A 18 0 1 
DHPS 14 1257856 G C P383A 22 8 6 
DHPS 14 1257858 G C P382R 7 0 0 
DHPS 14 1257859 G C P382A 0 5 0 
MDR1 10 361917 C G K1393N 4 0 0 
MDR1 10 362870 A G F1076L 14 2 12 
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MDR1 10 363169 T A Y976F 5 2 8 
MDR1 10 363223 G A T958M 22 10 13 
MDR1 10 363374 T G M908L 22 9 13 
MDR1 10 363514 G T A861E 3 0 0 
MDR1 10 364004 C T G698S 22 0 12 
MDR1 10 364557 A T S513R 6 0 3 
MDR1 10 364598 C T D500N 0 4 0 
MDR1 10 365435 C A V221L 0 3 0 
MRP1 2 154067 G A H1586Y 2 1 0 
MRP1 2 154249 G A T1525I 0 2 0 
MRP1 2 154391 C T V1478I 22 5 13 
MRP1 2 154567 C G G1419A 1 5 3 
MRP1 2 154646 A C Y1393D 22 8 13 
MRP1 2 154979 A T L1282I 0 2 0 
MRP1 2 155204 G T L1207I 21 0 1 
MRP1 2 156107 G C Q906E 21 6 11 
MRP1 2 158047 G C T259R 22 5 13 
MRP1 2 158122 G A T234M 21 0 1 
MRP1 2 158171 C A D218Y 0 0 2 
MRP1 2 158444 T C I127V 0 0 2 
MRP1 2 158717 T G K36Q 1 0 1 
MRP1 2 158795 G A R10C 0 0 2 
MRP2 14 2042200 G C H1960D 0 0 2 
MRP2 14 2043096 C G G1661A 0 0 4 
MRP2 14 2043285 C T S1598N 0 0 2 
MRP2 14 2043838 G A H1414Y 20 0 11 
MRP2 14 2043859 G C Q1407E 18 4 13 
MRP2 14 2044225 A G Y1285H 2 0 0 
MRP2 14 2044528 G A P1184S 0 3 0 
MRP2 14 2044658 G T S1140R 4 0 0 
MRP2 14 2044708 T G T1124P 1 0 1 
MRP2 14 2044749 A C V1110G 0 2 4 
MRP2 14 2044798 C A A1094S 0 5 0 
MRP2 14 2045050 C T V1010M 22 10 13 
MRP2 14 2045101 C T D993N 2 0 0 
MRP2 14 2047069 A G W337R 4 0 1 
MRP2 14 2047224 A C V285G 2 0 0 
MRP2 14 2047233 C A R282M 22 10 11 
MRP2 14 2047269 G C P270R 3 0 0 
MRP2 14 2047816 C G E88Q 4 4 4 
MRP2 14 2047893 C T,A C62Y,C62F 22 0 13 
MRP2 14 2047961 C T,G K39N,Syn 6 0 7 
P47 12 286327 C A F22L 22 1 12 
P47 12 286331 T C F24L 22 0 12 
P47 12 286340 A G K27E 22 1 12 
P47 12 286431 G C S57T 3 0 4 
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P47 12 286446 G A S62N 7 0 1 
P47 12 286949 G A V230I 15 0 4 
P47 12 286960 G T M233I 21 0 10 
P47 12 286970 T A F237I 2 0 1 
P47 12 287046 T C,A I262T,I262K 13 1 11 
P47 12 287078 A G I273V 8 0 2 
P47 12 287080 A G I273M 0 0 2 
P47 12 287379 C T A373V 16 1 6 
P48/45 12 289467 G A E35K 1 0 2 
P48/45 12 289995 C A H211N 22 3 13 
P48/45 12 290114 A C K250N 22 4 13 
P48/45 12 290367 G T D335Y 15 0 11 
P48/45 12 290421 G C E353Q 0 3 0 
P48/45 12 290490 G A A376T 14 0 10 
P48/45 12 290617 A G K418R 22 1 12 
 
 
Supplementary Table 4: Previously characterised 42 barcoding SNPs* in the 46 study 
isolates  
 
* from reference [51]  
 
Supplementary Table 5: Sites of population differentiation between Thailand and South 
America 
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Chr
. 
Position FST* Gene Product 
1 8396 0.758 PVX_087670 hypothetical protein, conserved 
1 137109 0.710 PVX_087775 E3 ubiquitin-protein ligase, putative 
1 422094 0.721 PVX_088090 hypothetical protein, conserved 
1 449291 0.710 PVX_088130 AP-3 complex subunit delta, putative 
1 638670 0.668 PVX_093565 hypothetical protein, conserved 
2 153642 0.853 PVX_097025 multidrug resistance-associated protein 1, MRP1 
2 174990 0.726 PVX_081215 hypothetical protein, conserved 
2 299845 0.924 PVX_081395 serine/threonine protein kinase, putative 
2 408852 0.716 PVX_081525 hypothetical protein, conserved 
2 416092 0.710 PVX_081540 ubiquitin carboxyl-terminal hydrolase 1, UBP1 
3 64629 0.694 PVX_001050 SET domain protein, putative (SET8) 
3 466211 0.849 PVX_000565 hypothetical protein, conserved 
4 295743 0.716 PVX_002815 hypothetical protein, conserved 
4 356929 0.924 PVX_002905 hypothetical protein, conserved 
4 481817 0.788 PVX_003935 amine transporter, putative 
4 618245 0.668 PVX_003780 hypothetical protein, conserved 
4 715122 0.716 PVX_003635 hypothetical protein, conserved 
4 812551 0.710 PVX_003535 Phist protein (Pf-fam-b) 
5 388029 0.767 PVX_089215 serine/threonine protein kinase VPS15, putative (VPS15) 
5 452949 0.664 PVX_089310 hypothetical protein, conserved 
5 591010 0.709 PVX_089480 hypothetical protein, conserved 
5 621120 0.726 PVX_089510 D13 protein, putative 
5 675424 0.668 PVX_089580 chaperone protein ClpB1, putative (ClpB1) 
5 972932 0.788 PVX_089960 hypothetical protein, conserved 
6 65601 0.709 PVX_001690 Phist protein (Pf-fam-b) 
6 171699 0.710 PVX_001830 hypothetical protein, conserved 
6 246827 0.779 PVX_001920 hypothetical protein, conserved 
6 268713 0.783 PVX_001950 hypothetical protein, conserved 
6 420885 0.664 PVX_111495 hypothetical protein, conserved 
6 521859 0.705 PVX_111370 hypothetical protein 
6 575464 0.709 PVX_111292 conserved Plasmodium protein, unknown function 
6 625419 0.779 PVX_111230 hypothetical protein, conserved 
7 68940 0.713 PVX_098625 hypothetical protein, conserved 
7 154973 0.709 PVX_098710 dynein heavy chain, putative 
7 174254 0.674 PVX_098712 high molecular weight rhoptry protein 3, RhopH3 
7 504372 0.788 PVX_099100 hypothetical protein, conserved 
7 568345 0.709 PVX_099180 type II NADH:ubiquinone oxidoreductase, putative 
7 726188 0.709 PVX_099375 hypothetical protein, conserved 
7 1019659 0.726 PVX_099750 hypothetical protein, conserved 
7 1038999 0.726 PVX_099780 replication termination factor, putative 
7 1064692 0.730 PVX_099820 hypothetical protein, conserved 
8 172625 0.924 PVX_094350 hypothetical protein, conserved 
8 573474 0.705 PVX_094855 NLI interacting factor-like phosphatase, putative (NIF4) 
8 730101 0.705 PVX_095010 ribonucleotide reductase small subunit, putative 
8 787639 0.716 PVX_095095 hypothetical protein, conserved 
8 829721 0.713 PVX_095145 hypothetical protein, conserved 
8 1502402 0.710 PVX_119390 hypothetical protein, conserved 
9 20038 0.664 PVX_090840 hypothetical protein 
9 77676 0.694 PVX_090895 hypothetical protein, conserved 
9 102780 0.716 PVX_090925 protein kinase domain containing protein 
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9 279221 0.713 PVX_091136 hypothetical protein, conserved 
9 659985 0.710 PVX_091630 hypothetical protein, conserved 
9 729619 0.709 PVX_091700 circumsporozoite-related antigen, putative (EXP1) 
9 1154029 0.769 PVX_092185 hypothetical protein, conserved 
9 1316937 0.713 PVX_092370 hypothetical protein, conserved 
10 667466 0.664 PVX_080425 transporter, putative 
10 671226 0.924 PVX_080430 phosducin-like protein, putative (PhLP3) 
10 800750 0.850 PVX_080615 hypothetical protein, conserved 
10 829185 0.708 PVX_080660 RNA pseudouridylate synthase, putative 
10 973520 0.712 PVX_098015 soluble NSF attachment protein (SNAP), putative 
10 975894 0.668 PVX_098010 hypothetical protein 
10 1003754 0.779 PVX_097980 transcription factor IIb, putative 
11 98032 0.924 PVX_115400 DNA repair endonuclease, putative (ERCC4) 
11 565497 0.849 PVX_114865 T-complex protein 1 subunit delta, putative (CCT4) 
11 920422 0.709 PVX_114495 acetyl-CoA synthetase, putative (ACS) 
11 1505435 0.710 PVX_113790 hypothetical protein, conserved 
11 1530963 0.726 PVX_113750 eukaryotic translation initiation factor protein 
11 1686293 0.730 PVX_113576 sorting assembly machinery 50 kDa subunit, SAM50 
11 1700734 0.674 PVX_113560 hypothetical protein, conserved 
11 1912448 0.668 PVX_113325 mitochondrial chaperone BCS1, putative 
11 1938368 0.775 PVX_113285 elongation factor G, putative 
12 174109 0.668 PVX_083360 tyrosine kinase-like protein, putative (TKL3) 
12 212484 0.779 PVX_083315 hypothetical protein, conserved 
12 225457 0.712 PVX_083310 translation elongation factor, putative 
12 339353 0.668 PVX_083185 isocitrate dehydrogenase [NADP], mitochondrial, IDH 
12 537177 0.726 PVX_082980 GPI mannosyltransferase 3, putative (GPI10) 
12 575061 0.705 PVX_082937 hypothetical protein, conserved 
12 890022 0.776 PVX_082470 elongation factor Tu, mitochondrial precursor, putative 
12 1173110 0.730 PVX_116655 hypothetical protein, conserved 
12 1307254 0.788 PVX_116805 hypothetical protein, conserved 
12 1403249 0.668 PVX_116930 conserved Plasmodium protein, unknown function 
12 1528154 0.721 PVX_117065 TLD domain-containing protein 
12 1588169 0.850 PVX_117145 transcription factor with AP2 domain(s), ApiAP2 
12 1623826 0.790 PVX_117175 dynein beta chain, putative 
12 1853264 0.664 PVX_117405 hypothetical protein, conserved 
12 2167573 0.790 PVX_117815 hypothetical protein, conserved 
12 2471252 0.701 PVX_118175 hypothetical protein, conserved 
13 307322 0.783 PVX_084445 cysteine repeat modular protein 3, putative (CRMP3) 
13 466345 0.674 PVX_084600 DnaJ domain containing protein 
13 503529 0.664 PVX_084640 hypothetical protein 
13 696401 0.775 PVX_084840 hypothetical protein, conserved 
13 725430 0.715 PVX_084860 hypothetical protein, conserved 
13 773964 0.783 PVX_084925 hypothetical protein, conserved 
13 1012549 0.705 PVX_085205 ABC transporter G family member 2, putative (ABCG2) 
13 1146760 0.783 PVX_085390 hypothetical protein, conserved 
13 1209407 0.726 PVX_085490 glutathione reductase, putative 
13 1673325 0.702 PVX_085955 cytidine diphosphate-diacylglycerol synthase, putative 
13 1773064 0.709 PVX_086035 transcription factor with AP2 domain(s), AP2-G2 
14 129079 0.712 PVX_121945 gametocyte associated protein, putative (GAP) 
14 188124 0.668 PVX_122015 sodium/hydrogen exchanger 1, putative 
14 918073 0.767 PVX_122845 hypothetical protein, conserved 
14 1058168 0.924 PVX_122995 transporter, putative 
14 1254772 0.668 PVX_123225 hypothetical protein, conserved 
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14 1256701 0.668 PVX_123230 
hydroxymethylpterin pyrophosphokinase-
dihydropteroate synthetase, putative (DHPS) 
14 1263307 0.668 PVX_123240 DEAD/DEAH box helicase, putative 
14 1296964 0.668 PVX_123283 JmjC domain containing protein (JmjC1) 
14 1314634 0.836 PVX_123300 hypothetical protein, conserved 
14 1416599 0.770 PVX_123395 GPI ethanolamine phosphate transferase 3, PIGO 
14 1963668 0.713 PVX_124005 hypothetical protein, conserved 
14 2432144 0.668 PVX_100865 cell cycle control protein, putative 
14 2759960 0.779 PVX_101265 cyclin g-associated kinase, putative 
14 2957235 0.721 PVX_101500 hypothetical protein 
API 22771 0.726 PVIV_000008700 sufB 
API apicoplast, all FST >0.68; bolded – known drug resistance loci 
 
Supplementary Table 6: Population informative apicoplast variants 
Chr. Pos 
Ref. 
Allele 
Alt. 
Allele 
FST 
Thailand 
vs. other 
FST 
SEA 
vs. 
other 
FST  
South 
America 
vs. other 
Gene 
API 1,416 G A 0.265 0.238 1.000 . 
API 2,461 A G 0.289 0.258 1.000 . 
API 5,562 A G 0.729 0.620 0.207 RPS8 
API 8,308 C T 0.720 0.625 0.186 RPS7 
API 16,619 T C 0.729 0.628 0.193 . 
API 18,222 G A 0.729 0.634 0.193 rpoC 
API 20,024 T C 0.729 0.634 0.193 rpoB 
API 22,668 G A 0.289 0.258 1.000 . 
API 23,740 A C 0.729 0.634 0.193 sufB 
API 23,829 C T 0.729 0.634 0.193 sufB 
API 26,441 C T 0.729 0.634 0.193 . 
SEA Southeast Asia 
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ABSTRACT 
 
Although Plasmodium vivax parasites are the predominant cause of malaria outside of sub-Saharan 
Africa, they are commonly neglected by elimination programmes. P. vivax is resilient and poses 
challenges through its ability to re-emerge, especially from dormancy in the human liver. With reports 
of growing drug-resistance and the increasing prevalence of life-threatening infections, there is an 
urgent need for tools that can inform elimination efforts. In order to halt transmission through 
effective intervention, malaria programmes need to identify reservoirs of infection and understand 
the dynamics of transmission and movement of parasite populations. The use of molecular 
epidemiology for tracking and studying parasite populations has been applied successfully to other 
malaria species such as P. falciparum. By assembling the largest set of P. vivax whole genome 
sequences (n=446) spanning 16 countries, and applying a machine learning approach, we created a 
71 SNP barcode with high predictive ability to identify geographic origin (93.4%) and infer 
transmission. Further, by using P. vivax data from a low-transmission setting in Malaysia, as well as 
other validation datasets, we demonstrate the ability to outperform published genotyping methods 
and infer outbreak events. When rolled-out in new portable platforms, this SNP barcode and its future 
data-informed machine-learning based improvements, will be an invaluable tool to help elimination 
efforts of this resilient neglected Plasmodium species. 
 
 
Word count: 213 
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Plasmodium vivax, SNP barcode, geographic origin, transmission 
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INTRODUCTION 
Plasmodium vivax is the predominant cause of malaria outside of sub-Saharan Africa 1,2 with increasing 
reports of drug-resistance and severe complications that pose a threat to children and pregnant 
women 3–6. Elimination efforts have led to reductions in the prevalence of the deadlier P. falciparum 
malaria, but areas of co-endemicity have seen a corresponding rise in P. vivax infections, which appear 
more resilient to control strategies7. In order to halt transmission, malaria programmes should focus 
on identifying the main reservoirs of infection and adapt control measures to efficiently tackle these. 
P. vivax has been observed in regions where malaria transmission had once been interrupted 8, 
therefore long-term monitoring is essential. Further, understanding the transmission dynamics of the 
parasite populations through assessment of genetic diversity has the potential to play a key role in 
guiding the elimination efforts, including by revealing transmission events and identifying potential 
foci of infection. In recent years, genomic studies have dissected the molecular dynamics of P. vivax 
populations in regions with stable transmission 9–13 . Other studies have used microsatellites to study 
trends in the population dynamics 14–17. The availability of whole genome sequencing data can inform 
the design of “genetic barcodes” for inferring transmission and geographic source of infections, and 
when combined with affordable delivery systems, can facilitate P. vivax epidemiological and 
surveillance investigations.  
By leveraging off whole genome sequencing for population characterisation 11,12,18,19, a number of SNP-
based barcodes have been derived for P. falciparum.  A barcode based on 24 SNPs in the nuclear 
genome (“24-SNP barcode”) has been used to identify and track isolates from an endemic population 
in Senegal 20. Although it was designed using only a limited set of long-term adapted laboratory lines 
20, the barcode has demonstrated local changes in genetic diversity across a 7-year period 21, as well 
as the potential effectiveness of such tools  in combination with epidemiological methods to elucidate 
transmission intensity in a malaria endemic region 21. Nevertheless, the use of isolates from a very 
limited region to generate the barcode, can potentially underestimate the genomic variability present 
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in other Plasmodium populations in the global setting, impeding the transportability of the 24-SNP 
barcode to other geographical settings. Further, it has been shown that the predictive power of the 
24-SNP barcode for geographical determination is poor,  especially when compared to one formed of 
23 SNPs from the mitochondria and apicoplast organellar genomes, which predicted the continental 
origin of samples with 92% accuracy 22. Another barcode formed of 105 highly frequent nuclear 
genome SNPs was developed to infer transmission intensity using a much broader panel of data, 
thereby proving greater utility across malaria-endemic countries 23. Overall, these studies in P. 
falciparum have demonstrated that SNP barcodes can potentially provide insights into the intensity 
of transmission, identify the geographical origin of the field isolates, and inform the dynamics of the 
diversity in a parasite population including outbreak identification, an event which has been shown to 
be more likely in low-transmission settings 24. 
For P. vivax there have been two attempts to generate SNP barcodes 25,26, including a “42-SNP 
barcode”, for ascertaining the source of infection. However, these barcodes were based on small 
datasets with limited geographical coverage, and therefore have poor predictive power when used 
for more global applications 11–13,27. With technological advancement in genomics, including the high 
throughout sequencing of candidate genomic regions and portable genotyping 28, the identification 
and integration of informative loci for P. vivax and other plasmodium parasites for inferring 
transmission and infection source, has the potential to revolutionise global malaria surveillance. Here, 
using whole genome sequencing data for 446 P. vivax isolates across 16 countries, we applied machine 
learning and SNP tagging approaches from human genome-wide association studies (GWAS) to create 
a 71 SNP barcode with the high predictive power for geographic origin (93.4% accuracy) and the ability 
to infer transmission. We demonstrate that the barcode outperforms alternative approaches, 
including microsatellite genotyping, for global geographical profiling and inferring outbreak events 
within a low-transmission setting in Malaysia. The “71-SNP” barcode has the potential to be an 
invaluable tool to help elimination efforts of this resilient neglected Plasmodium species.  
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RESULTS 
SNPs, samples and population structure 
We aligned raw sequence data from 867 isolates 9,11–13,29 to the PvP01_v1 (http://genedb.org) 
reference genome, and identified 1,522,046 SNPs. Isolates with high levels of missing genotype calls 
(>30%) and high multiplicity of Infection (>20% heterozygous genotypes) were excluded from analysis. 
The final dataset was formed of 446 isolates, spanning 16 countries and 6 regions (Africa 3; South Asia 
4; Southeast Asia (SEA) 264; Papua New Guinea 26; South America 129; North America 20), and 
741,074 high quality SNPs of which 86% were non-common (minor allele frequency (MAF) < 5%) 
(Supplementary figure 1, left), consistent with previous findings 27.  
 
A principal component analysis (PCA) revealed that the isolates clustered broadly by regional groups: 
SEA (Thailand, Myanmar, Cambodia, Vietnam and Laos), South Asian/SEA (China), Americas (Peru, 
Colombia, Mexico and Brazil) and Oceanian/SEA (Papua New Guinea, Indonesia and Malaysia) and 
others located around the Arabian Sea (Figure 1). At a country level, the intra-border genomic distance 
between isolates was on average smaller (mean: 26,505 SNPs, range: 0 - 37,801 SNPS) compared to 
the inter-border distance (mean: 33,160 SNPs, range: 6,034 -39,676 SNPs), in line with previous 
studies 11,12. The notable exception to the pattern was isolates sourced from neighbouring Thailand 
and Myanmar, supporting evidence they belong to a similar parasite population 11. These patterns 
suggest the possibility of identifying markers that could potentially identify geographic origin to the 
country level in most cases. Intuitively, the highly skewed distribution of the MAF towards rare 
variants suggests that more common SNPs are those driving the population structure observed. To 
assert this observation, we split the dataset in three equally sized divisions based on MAF (tertiles: 
<0.2%, 0.2 – 1.3%, >1.3%; Supplementary figure 1, right), and for each constructed neighbour-joining 
trees and correlated the pair-wise genome distance with the estimate based on all 741k SNPs (Figure 
2). These comparisons revealed the strong explanatory power harboured by those SNPs with the 
highest MAF (correlation 0.93 with the full 741,074 SNP set) compared to the subsets with lower MAF 
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(correlations of 0.14 and 0.18). A MAF cut-off (> 0.3) was determined (Supplementary figure 1, right), 
leading to a subset of 16,075 SNPs used as the starting point for barcode building for country 
classification. 
 
Selection of highly informative barcoding SNPs using a tagging and machine learning approach 
In order to further reduce number of markers used for barcoding construction, we applied the 
software TAGster 30 to identify tagging SNPs that summarise blocks of high linkage disequilibrium (LD), 
as estimated by the correlation metric r2 across windows of size 500 kbp. The genetic variability can 
be captured by tagging SNPs due to the strong LD structure found in P. vivax populations 27, and we 
identified 1,173 SNPs, which summarised variation in 4,896 neighbouring SNPs, almost 40% of the 
total dataset.  The 1,173 highly informative SNPs were then used as the pool for a further selection 
using a random forest modelling approach. Prior to implementation, missing alleles (4.4%) were 
imputed with high accuracy (<1% error, see Online Methods), and a neighbour joining tree was 
constructed using the resulting data, thereby confirming that no bias was introduced to the clustering 
patterns (Supplementary figure 2, top). We sought to show that the 1,173 SNPs predict not only large 
geographic differences within isolates, but also similarities within intra-border isolates. In particular, 
we studied the correlation of genome distance based on 1,173 SNPs against those representing intra 
regions (genomic distance < 20,000 SNPs) (Supplementary figure 2, bottom). This analysis revealed 
that the 1,173 high frequency tagging SNPs can not only detect strong inter-border differentiation but 
also closely related samples within the same country based on genomic distance (r2 = 0.96).  
 
Application of the random forest classification approach to the classification of country involved 
constructing 500 trees, partitioning the dataset randomly into 80% training (n=357) and 20% for 
validation (n=89), and using 34 variables at each nodal split. Classification error rates became stable 
when 100 trees were averaged (Supplementary figure 3, left). The final model performed with an 
overall out-of-bag error rate of 17.6%, where the main classification errors were found across 
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Southeast Asian populations (Thailand, Vietnam, Cambodia, and Myanmar), which were identified as 
highly related populations using the genomic distance (Figure 2, right), as well as by others 11. The 
random forest model was then used to identify the 60 SNPs with the highest predictive importance 
across the trees (Supplementary figure 3, right). A further 11 SNPs were chosen to summarise strong 
inter-countries based on the fixation index (FST > 0.7), leading to a final barcoding set of 71 SNPs (Table 
1).  Within this SNP set, there are differences in allele frequency across the two main regions 
(Southeast Asia and South America), but no markers were fixed across the populations. The 71 
markers are in low LD (Supplementary figure 4) (r2 mean: 0.151, Inter-quartile range: 0.019 - 0.235), 
but some blocks of correlation are observed, which can be explained by an uneven geographic 
distribution of the isolates. 
 
In order to assess the potential of the barcode for geographic classification, a PCA was generated using 
only the 71 SNPs (Supplementary figure 5, top), and similar clustering patterns were observed to 
those using the genome-wide (741k including a “42-SNP barcode”) SNPs (Figure 1). When comparing 
the genomic distance obtained using the 71 barcoding to genome-wide SNPs (n=741,074) in intra-
borders pair-wise comparisons, we observed 88.3% correlation proving the potential of this barcode 
to not only identify geographical origin but also provide insights into the relatedness of intra-border 
isolates (Supplementary Figure 5, bottom). The potential to infer intra-border relatedness and 
therefore, provide insights into transmission dynamics, was also supported by the fact that 87.9% 
(392/446) of the haplotypes obtained were unique in the dataset. Furthermore, the 71-SNPs were 
used to blindly predict the geography of the 20% of the isolates (n=89) not used to develop the random 
forest, and were complemented by a further 16 Brazilian in-house sequenced isolates. The model 
using only the 71-SNPs yielded an overall accuracy of 93.4% (6.6% out-of-bag error) and predicted 
correctly the origin of all the provided isolates. It outperformed a published 42-SNP barcode 26, which 
under the same random forest model conditions (80%/20% training/prediction and 500 trees) 
obtained a 79.3% accuracy. The low accuracy of the 42-SNP barcode can also be observed in the 
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ambiguous clustering found in the PCA (Supplementary Figure 6, top) and neighbour-joining tree 
(Supplementary Figure 6, bottom). Furthermore, this SNP barcode showed a low correlation with the 
genome-wide (741k) SNPs distance (r2= 0.60). 
 
In-silico testing of the barcode in a near-elimination setting in Malaysia. 
 
A field-ready SNP barcode with the potential for being deployed in low-transmission settings has to 
be proven efficacious in settings where the identification of foci of infection and imported cases are 
of key relevance. We used an independent dataset comprising 60 P. vivax isolates, sourced from Sabah 
Malaysia, where the genomic population dynamics have been extensively studied using microsatellite 
markers and whole genome sequencing methodologies 24. In silico application of the 71-SNP barcode 
identified two main populations (referred to as K1 and K2), where one (K2) comprised of 26 almost 
genetically identical isolates in a known transmission outbreak, previously supported using a set of 9 
microsatellites 24. Using the 71 SNPs the estimated the genetic distance across isolates was strongly 
correlated with genome-wide SNP-based estimates (r2 = 0.83). A PCA plot based on 71-SNPs revealed 
the two distinct populations (Figure 3A; K1 grey; K2 yellow), and the outbreak isolates from K2 tightly 
clustered and shared the same available haplotype across the 72 SNPs. There was one notable 
exception (ERR1475456) which presented a larger genetic distance (Figure 3A, green label). This 
isolate shared the same microsatellite haplotype as the outbreak K2, but the distribution of genomic 
distance when compared to the rest of the outbreak samples was greater, thus being less related to 
the outbreak isolates and potentially being an error in the genotyping (Figure 3B). Furthermore, the 
generation of a neighbour-joining tree using the 71 SNPs revealed clustering by administrative division 
in Sabah Malaysia, which could be used for tracking of cases from different health authorities (Figure 
3C). Altogether, these results show the potential of the 71-SNP barcode (or future versions with data-
driven machine learning updates) to be used in field settings, not only to predict geographical origin 
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but also to infer transmission events. The Malaysian analysis highlights its utility in low transmission 
and near-elimination settings. 
 
DISCUSSION 
Plasmodium vivax accounts for a high global malaria burden, with marked incidence outside of sub-
Saharan Africa 2, and growing levels of drug resistance and severe human infections 31–33. The 
resilience of the parasite, especially its re-appearance in regions where malaria transmission had 
previously been halted 8, poses strong challenges to malaria elimination. Microsatellite genotyping 
has been used to study P. vivax genomic and population dynamics, but it underestimates variability in 
natural populations34, as shown in our analysis. Whole genome sequencing is the gold standard 
approach, but is currently logistic- and cost-inefficient for large genomic epidemiological studies, 
especially in under-resourced endemic areas. To bridge the gap, we have a developed a 71 SNP 
barcode, informed by whole genome sequencing data from 446 isolates across 16 different countries 
worldwide. To date, barcodes in Plasmodium species – particularly P. falciparum - have focused on 
determination of the geographical origin of the samples using nuclear or organellar genomic markers 
22,25, or to infer transmission intensity using the frequency of unique haplotypes 21,26 or by modelling 
the complexity of the infections 23,  but not together as adopted here. Further, P. vivax barcodes have 
been based on small datasets and they have been demonstrated to target specific geographic 
populations 27, rather than our global approach that is more robust to the potentially high mobility of 
individuals through access to  air travel. In fact, application of a 42-SNP barcode26 to our dataset led 
to a lower accuracy (79.3%) when predicting origin of the isolates at a country level. The barcode also 
performed sub-optimally when estimating SNP-based relatedness of isolates, and therefore may not 
be suited to the inference of intra-border transmission. 
 
Our barcode was constructed by recognising that common SNPs are more robust markers and harbour 
greater explanatory power for both geographical and transmission inference. By triaging SNPs using 
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established linkage disequilibrium tagging methods, it was possible to apply random forest 
methodology to select 60 markers, augmented by 11 inter-continental SNPs, to accurately predict 
country (93.4%), with an 6.6% out-of-bag error. Whilst there are alternatives to the random forest 
algorithm, it has become an established data analysis tool in bioinformatics, with an excellent 
performance in settings where the number of variables is much larger than the number of 
observations. Further, the methodology has an ability to explore complex interaction structures and 
highly correlated variables, and return useful measures of variable importance 35,36. The set of 
“important” SNP predictors of country determined by the random forest approach was robust to initial 
model parameterisation, and the final model and set of SNPs were validated perfectly on a 20% subset 
of the original samples augmented by prospectively collected ones from Brazil.  The 71-SNP barcode 
and intermediate SNP sets informing its construction were used to reconstruct principal components 
plots. These plots were consistent with the overall population structure based on 741k markers, and 
therefore confirm there was no major loss of geographical specificity.   
 
Overall, our 71-SNP barcode is the first that shows such strong levels of accuracy in geographic 
prediction in P. vivax for a highly diverse dataset, making it a highly valuable tool for the detection of 
imported cases of malaria. Further, as whole genome data becomes available, especially from sites 
with currently poor coverage such as central America, Africa and south Asia, the machine learning 
approach can rapidly update the SNPs in the barcode. The barcode was also designed to be able to 
provide information about potential transmission trends and therefore be useful in field settings, 
where large genomic differences are less likely, with the exception of imported cases. The proportion 
of unique haplotypes identified across the dataset was high (88%; 392/446 haplotypes observed), 
which allows greater scope for informing on intra-border haplotype diversity, including low diversity 
such as in an outbreak setting. This utility was demonstrated by the use of intra-border highly related 
isolates, where we confirmed that the SNP distances based on the 71-SNP barcode and genome-wide 
741k markers were highly correlated, and represent an improvement on comparative reported values 
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for microsatellites (r2 = 0.70)34. Further, the use of the 71 SNP barcode was validated in silico using 
data from 60 P. vivax sourced from a low endemic and near-elimination setting in Malaysia, where it 
was possible to partition the population into highly structured subclades and confirm the presence of 
an outbreak cluster, previously identified using both microsatellite genotyping and sequencing. Also, 
by using the 71 SNP barcode we identified a misclassified “outbreak” isolate with an identical 
microsatellite haplotype, and evidence of regional clustering by the different administrative divisions, 
further supporting the utility of the tool and superior performance to microsatellite genotyping.  
 
In summary, we have presented a new molecular barcode for P. vivax that can provide information 
on both geographical origin and on closely-related isolates within country borders to help infer 
transmission events and identify foci of infection. The 71-SNP barcode out-competes previous 
genotyping methods and is a powerful and affordable solution that could potentially enable the 
execution of large genomic epidemiological studies, with high throughput assessment of large 
numbers of parasites. By leveraging off growing and large datasets of whole genome sequencing data, 
and the power of machine learning algorithms, it will be possible to update the barcode, augment it 
with drug resistance markers, and implement it rapidly in field-based settings using portable 
technologies. Ultimately, insights into genetic diversity will assist the much-needed understanding of 
the dynamics of P. vivax populations and inform clinical and disease control decision making. 
  
MATERIALS AND METHODS 
 
Genomic data generation 
 
Illumina sequenced data from previous studies 11–13 was downloaded from ENA repository to form a 
total dataset of 834 isolates. Each isolate data was mapped against the PvP01_v1 reference (obtained 
from http://genedb.org) using bwa-mem 37. SNPs (n=1,522,046) were called from the resulting 
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alignments using  samtools software suite 38, as previously described 27. Isolates and SNPs were 
excluded if presenting with >20% missing or heterozygous genotype calls, and further SNPs were 
removed if from hypervariable gene regions (e.g. vir genes). The final dataset consisted of 741,074 
high-quality SNPs and 446 isolates. 
 
Population Structure and tag SNP selection 
 
The 741,074 high-quality SNPs and its subsets were used calculate matrices of Manhattan distance 
between samples. These matrices were used to generate principal component analysis plots and 
neighbour-Joining trees (R ape package 39). The Pearson’s r2 metric, calculated using the R base 
function cor, was used to estimate the correlation between distance matrices. The software TAGster30 
was used to identify SNPs which summarise blocks of high linkage disequilibrium, as estimated using 
the genetic r2 metric.  We specified an r2 threshold of at least 0.7 for inclusion in a block and a window 
size of 500 kbp, leading to 16,075 SNPs with minor allele frequency > 0.3 being included for analysis. 
The resulting 1,173 tag SNPs identified were then further characterized for downstream analysis. 
Fixation index (FST) was calculated using in house scripts in R. 
 
Barcode SNP selection using Random Forests (RF) 
The selected 1,173 highly informative SNPs obtained using a combination of minor allele frequency 
and tag SNP approaches were extracted from the original dataset and imputation was performed on 
the missing data points (4.4%) in the dataset using the R package missForest40. This yielded an 
estimated out-of-bag error in the imputation of 16.2% which left a total of 0.7% potentially erroneous 
calls. After imputation, a random selection of 80% of the dataset was assigned as training set and the 
remaining 20% was assigned as test dataset and country was tested as the predicted variable. Then, 
500 trees were calculated using the RandomForest41 package in R in order to determine the SNPs in 
the dataset with highest importance for classification of samples into countries. We then selected the 
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60 SNPs with highest importance and used the R package LDcorSV42 to calculate the correlation 
between the markers. Further PCA plots and neighbour-joining trees were calculated for this subset 
of SNPs.  
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FIGURES 
Figure 1. Principal component (PC) analysis plot generated using 741,074 high quality SNPs across 
446 P. vivax isolates reveals geographic clustering. Isolates were coloured according to country of 
origin. Clustering by region can be found, with Southeast Asian isolates appearing cluster at the 
bottom right of the plot, Oceania at the top right, and South American isolates clustering on the 
centre left side of the plot. A relative degree of clustering by country can be observed, especially for 
isolates from Oceania and to a lesser extent Southeast Asia. 
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Figure 2. Subsetting of SNPs by minimum allele frequency (MAF) reveals the strong explanatory 
power of high frequency SNPs in P. vivax. Three equally sized divisions (i.e. tertiles) of the SNP dataset 
were used based on MAF, left [0 - 0.2 %], centre [0.4 - 1.3 %] and right [1.3 – 50 %]. Each of these 
subsets were used to construct a neighbour-Joining tree (top) revealing only clear geographic 
clustering when the high frequency SNPs are used (right). Furthermore, the correlation of the genome 
distance calculation using all SNPs and each subset separately, reveals the poor correlation for the low 
frequency SNPs (0.14, left and 0.18, centre) and a strong correlation for the high frequency subset 
(0.93, right). 
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Figure 3. Use of 71 SNPs barcode in P. vivax isolates from Sabah, Malaysia reveals patterns of 
transmission. A dataset of 60 isolates from a near-elimination setting that has been exhaustively 
characterised by whole genome sequencing in 24 was characterized by means of a PCA using the 71 
SNP barcode from this study (A). The PCA revealed a highly fidelity to the results obtained in the study 
using whole genome sequencing, with the outbreak population K2 (yellow in A and 1 in legend) 
clustering together. The only isolate showing distant clustering (ERR1475456) was further 
characterized using the genome distance by pair-wise comparison to other outbreak isolates (B) 
showing it not to be as closely related to the outbreak as indicated by microsatellite genotyping in 24. 
Furthermore, a neighbour-joining tree was generated and coloured according to their district in Sabah, 
and revealed clustering patterns of the samples from the West Coast Division in Sabah (C). 
 
(Figure on pages 226 [A and B] and 227 [C] ) 
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TABLES 
Table 1. Selection of 71 barcode SNPs for Plasmodium vivax. The barcode has both geographic origin 
prediction power and transmission inference ability. A certain degree of clustering across populations 
is found in the SNPs without complete fixation, allowing for increased number of haplotypes to be 
traced and transmission events to be investigated, the colours represent the gradient from 0 to 1 of 
the frequency of each SNP in each population, blue for highly frequent SNPs and red for low frequent 
SNPs. 
 
(Table in next page) 
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SUPPLEMENTARY INFORMATION 
 Supplementary Figure 1. (Left) Distribution of SNPs according to minor allele frequency (MAF); 
(Right) SNPs partitioned into three equally sized divisions based on MAF (blue dashed lines), and a 
cut-off of MAF >0.3 (red dashed line) was used to pre-select SNPs for downstream analysis. 
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Supplementary figure 2. (Top) Neighbour-joining tree based on 1,173 tagging SNPs in P. vivax selected 
using the TAGster 30 software shows strong similarity with the  tree from Figure 2 (right), observing a 
strong geographical signal; (Bottom) The correlation of genome distance based on whole genome 
sequencing (WGS; 741k SNPs) with the subset of tagging (1,173) SNPs is high (r2 = 0.96). 
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Supplementary figure 3. (Left) Classification error for the different geographic categories across the 
500 trees in the random forest model reaches stability when 100 trees are averaged (OOB). (Right) 
Variable importance estimated from the random forest model for the number of 1,173 tag SNPs. The 
red dashed line is the cut-off based on importance, which is the threshold used to determine SNP 
inclusion in the barcode based on the SNPs with the highest importance. 
(Figure in next page) 
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Supplementary Figure 4. Correlation of the 71 SNP barcode for Plasmodium vivax. Low overall 
correlation was found between the 71 SNPs selected (mean r2= 0.15). Blocks of correlation were 
observed which correspond with SNPs with geographic signal (i.e. Southeast Asian high frequency 
SNPs).  
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Supplementary Figure 5. PCA plot reveals geographic clustering of Plasmodium vivax isolates using 
71 SNPs barcode.  Clustering by region and by country was observed when using the 71 SNP barcode 
as observed in the top panel. Furthermore, a strong correlation of 0.88 was observed between the 
distances based on whole genome (n=741k) and 71 barcoding SNPs, revealing the potential for the 
barcode to identify closer related intra-border isolates. 
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Supplementary Figure 6. The PCA plot and neighbour-joining tree using a previously published 42-
SNP barcode 26 shows ambiguous geographic clustering of Plasmodium vivax isolates.  Geographical 
clustering by region was apparent, although a degree of overlap was observed and separation by 
country was not clear. This result is suggested by the low accuracy (79.3 %) obtained when predicting 
geographical origin using a random forest model formed with the set of 42 SNPs. 
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Chapter 8 
Discussion and Conclusion 
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DISCUSSION 
 
This thesis covers the population genetic analysis of whole genome sequencing data from isolates of 
Plasmodium malaria infections. In Chapter 2, the PacBio long-read sequencing technology was used 
to generate a new highly robust reference genome for the zoonotic P. knowlesi human-adapted strain 
A1-H.1 1. Advances in the use of this parasite strain in the laboratory have allowed the in vitro culture 
of P. knowlesi using human blood, thereby avoiding the use of difficult to access macaque blood. 
Concerns have been raised about the quality of the assembly of the available P. knowlesi H strain 
reference 2, therefore the generation of this new reference can be a useful alternative or comparative 
resource. Use of the A1-H.1 reference led to superior mapping coverage across the available Illumina 
isolate collections, out-performing the H strain. The use of PacBio sequencing can also provide insights 
into methylation events in the genome. The coverage levels obtained in the sequencing did not allow 
for the detection of m5C methylation events, which have shown to be of relevance in P. falciparum3. 
However, I reported here for the first time the presence of m6A and m4C methylation events in the 
P. knowlesi genome, which have been observed in other eukaryotic organisms 4 where they are 
thought to play a role in transcription regulation 4. Furthermore, several regions within the genome 
with a higher density of methylation events were identified. These regions included several 
methyltransferases and the NBPXa gene, which is an essential gene for human red-blood cell invasion 
5. The robust reference genome and the insights described here, in conjunction with the ability to 
culture P. knowlesi in-vitro, create the perfect framework to allow for follow-up studies of parasite 
biology. Potential studies could involve the use of RNAseq sequencing to investigate the possible 
impact of the epigenetic events on transcription levels and regulation, similar to investigations in other 
organisms 6. Furthermore, the use of new molecular technologies like genome editing will make it 
possible to understand the biology of the parasite. CRISPR editing has been successfully applied to 
other Plasmodium parasites 7. A robust, strain-specific reference genome is a highly primordial tool 
for the design of genetic and molecular experiments, for example, producing mutants that would 
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allow the study of the role played by different genes in the parasite life cycle. This approach has been 
previously performed with invasion-related genes in P. knowlesi  5. 
 
In Chapter 3, the mapping of all the available short-read Illumina sequenced isolates against the A1-
H.1 reference was performed. Studies have shown that application of erroneous bioinformatic 
analytical approaches to Plasmodium isolates with complex infections (multiplicity of infection  [MOI] 
> 1) could bias the results 8. By applying a stringent filtering of isolates presenting high MOI, a more 
complex population structure is revealed that is complementary to the previously described genomic 
clusters associated with either Peninsular Malaysia, or one of the two macaque species that are 
natural hosts for P. knowlesi 9. The genomic comparison of the two new regional clusters in Betong 
and Kapit belonging to the long-tailed macaque cluster (Mf-Pk) revealed the presence of mosaicism in 
their haplotypes (determined initially by allele frequency differences using FST). These mosaicisms 
were determined to be introgression events from the pig-tailed genomic cluster (Mn-Pk). This is the 
first report that the two host-specific subpopulations of P. knowlesi are not genetically isolated, as it 
was previously thought 10. An in-depth study of the genomic composition of the individual isolates 
revealed the introgressed fragments to be present across multiple isolates and spanning all 
chromosomes in the genome. Despite this, the only strong signal of selection for such fragments was 
found in a chromosome 8 region, harbouring genes related with mosquito life stages of the parasite, 
suggesting a possible mosquito-driven effect in the parasite genome. Analysis of organellar genomes 
also supported introgression and suggested the possibility of such events occurring in non-recent 
times. This is the first time that such strong and recent events are described in any Plasmodium 
parasite, and the relevance of such events in the context of the ecological change that Malaysian 
Borneo is experiencing is still to be determined. In the future, studies that focus on understanding the 
geographical breadth as well as the population depth of these events would be of high importance. 
Prospective studies with representative sampling from each of the different regions in Borneo would 
be required to understand the extent of introgression. Compartmentation of the geographical areas 
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based on ecological characteristics such as land use (forest, plantation, urban, transition between 
them), and mosquito vector distribution could help elucidate what factors might be driving such 
exchanges. Further, the study of retrospective samples collections could provide insights into the 
historical relevance of such events and whether they played a role in the establishment of the genetic 
subpopulations observed currently in Malaysian P. knowlesi parasites.  
 
Building on the introgression insights, and in order to overcome the difficulty to sequence low-
parasitiemia infections of P. knowlesi infections, a new methodology for selective whole genome 
amplification (SWGA) was implemented and tested in several newly collected isolates from both 
Peninsula and Borneo Malaysia (Chapter 4). The new methodology had been previously used in other 
Plasmodium species 11,12 and primers specific for P. knowlesi were designed. The new method yielded 
a significant improvement in overall parasite DNA concentration compared to human DNA for almost 
all the samples tested. This approach led to ~40% of the genome covered with at least 5 reads, thereby 
allowing the calling of SNPs. Using laboratory data generated by our group, it was possible to 
demonstrate that the method is reliable to amplify sample isolates across all three subpopulations of 
P. knowlesi, including some complex infections (MOI > 1). This approach demonstrated that although 
the previously sequenced laboratory strains had been collected long ago from Peninsular Malaysia, 
they still are representative of this subpopulation when compared to the recently collected isolates. 
Further investigation of the Peninsular isolates revealed signatures of introgression events, which 
seemed to originate from the Mn-Pk subpopulation. However, in this case the genes affected did not 
seem to be associated with mosquito-related genes, but with invasion related loci such as DBP and 
NBPXa, as well as exported proteins from the subtelomeric regions. This observation, although 
represented only by single case events, might suggest that these introgression events also can affect 
invasion related genes, where differences in the haplotypes of the DBP gene have shown to affect 
binding affinity of such proteins to human receptors 13. It is worth noting that given that the 
haplotypes observed originate from human infections, they are all thought to be able to invade human 
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red blood cells, and therefore might not be a good representation of the natural pool of invasion 
haplotypes in the macaque reservoir host. Despite this, the dynamics of these human-selected 
haplotypes are of relevance as they might provide different invasion efficiencies and could be of 
relevance in order to understand the spread of this newly emerging form of human malaria. A 
comprehensive study of the introgression patterns in the 5 P. knowlesi RBP and DBP genes revealed 
that extensive exchange events have occurred within the NBPXb gene for the Borneo subpopulations 
MF-Pk and Mn-Pk, which suggests more complex patterns related to the invasion dynamics of the 
different clusters. Follow-up work could involve additional sampling of isolates, with linked GPS 
coordinates. Microsatellite data has shown that the distribution of the clusters across regions of 
Peninsular Malaysia is uneven 9, and exploring how this distribution correlates with introgressions 
would assist with understanding how these events arose. Furthermore, data collected in a longitudinal 
manner would provide insight into whether these events are sporadic, self-contained or are currently 
spreading across the population. The biology underlying the events could be explored using CRISPR 
systems 7. For example, the different haplotypes found to be introgressed could be inserted into a 
laboratory strains (e.g. A1-H.1), thereby assessing their efficiency on invading human red blood cells, 
and providing insights into how these exchanges respond to natural adaptations to new, more 
efficient invasion routes. This new finding suggests that other biologically relevant pathways can be 
targeted and studying such event will help understand how these deeply differentiated populations 
originated, helping to understand whether this phenomenon is due to adaptation to the host 
macaques, the anopheline vectors or both.  
 
Like P. knowlesi, the population structure of P. falciparum is broadly geographically distributed and 
differentiated. However, it is unclear if highly variable gene families can be used to barcode the 
geographical source of infections. In Chapter 5 a study of the genetic and structural diversity of a 
vaccine candidate and a key functional gene related with malaria in pregnancy, the var2csa, is shown. 
Given the hypervariability of this gene, mapping strategies do not succeed at unravelling the genetic 
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diversity. Therefore, I used the long-read sequencing technologies to generate robust sequences 
spanning the whole gene for several laboratory strains and clinical isolates, and to confirm the 
presence of isolates with extra genic copies and the degree of similarity of the copies found. The short-
read sequencing was then used on the same isolates to establish a pipeline to identify samples with 
extra gene copies and to map distribution of such isolates geographically, identifying an increased 
prevalence of isolates with extra different copies in West African populations. Using these same 
isolates, I established a de-novo assembly pipeline and calibrated it using the long-read assembled 
genes and generated a set of more than 1,200 sequences spanning almost 80% of the gene (>7 kbp). 
These sequences allowed the study of the diversity of the amino-acid sequence of the ID1-DBL2Xb 
region, which includes the minimal binding domain of the CSA receptor 14 where the protein binds and 
is the target of both vaccines currently in Phase 2 clinical trials15,16. I identified 4 clades of sequences, 
two of which had been previously described 17 and Cluster 1 had been associated with low birthweight 
in pregnancy in West Africa 17. Furthermore, mapping the clades geographically showed Clade 1 to be 
present across all the populations, although at different frequencies. Moreover, higher diversity was 
found in African populations than in Southeast Asian populations and two of the Clades seemed 
predominantly African. From a within gene diversity perspective it was found that the ID1-DBL2Xb 
region, which is the main target of the two main vaccine candidates, harbours a surprisingly high 
number of small, low frequency insertions and deletions. This high level of polymorphism prevents 
the correct calculation of the nucleotide diversity in this region and underestimates the overall 
diversity. The impact of such small structural variants is yet undetermined, especially with respect to 
both binding affinity to the CSA receptor during pregnancy and vaccine antibody recognition. One 
approach could involve grouping var2csa gene variants based on the different clades, the generation 
of consensus sequences for each clade, and then an assessment of the impact of inter-clade 
differences in binding with the CSA receptor. Currently, new protein structure modelling algorithms 
are being developed in order to estimate the effect that combined mutations might have on the 
binding affinity and functionality of other proteins in P. falciparum 18 and other organisms 19. The 
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application of similar approaches could streamline the study of the impact of such diversity patterns 
in the functionality of the VAR2CSA protein. Further, a study of the diversity of the CSA receptor in the 
human host could also be performed. This approach could reveal whether diversity patterns respond 
to host-associated adaptation, and would require the collection of host and parasite samples from 
clinical cases. 
 
The study of the P. vivax malaria parasite has historically been neglected in favour of the deadlier P. 
falciparum species 20. In order to design barcodes that can tackle the study of such species in an 
epidemiological manner, firstly genomic diversity and population structure of this parasite has to be 
investigated. In Chapter 6 I collated the largest collection of P. vivax whole genome sequenced clinical 
isolates publicly available at the time, and performed a genomic diversity analysis. Using the SNPs 
found across the dataset it was possible to confirm that P. vivax parasites harboured more genetic 
diversity than P. falciparum, and that the two main populations in Southeast Asia and South America 
present a greater genetic distance compared to Africa and South East Asia for P. falciparum. It is worth 
mentioning that due to the high level of MOI observed (present in 47% of isolates) and the approach 
followed, using the major calls; therefore studying the most abundant strain in each sample, the 
results obtained would underestimate the level of genomic complexity in these isolates. Construction 
of a neighbour-joining tree confirmed the presence of clustering by geography, in particular, a South 
American collection of isolates from different countries and a South East Asian population, mainly 
consisting of isolates from Thailand. Using these populations, genetic regions with allele frequency 
differences revealed using the FST metric and selection pressure methods were detected, and loci 
belonging to mosquito life-stages related genes and drug resistance (e.g. MRP1 and DHPS) were 
identified. Furthermore, novel deletions in the MDR1 gene promoter region, and gene duplications in 
the PvDBP invasion-related gene were found. SNPs with regional classification power where found in 
the apicoplast, and the analysis of mixed infections, revealed the power of the mitochondrial genome 
to be used as a barcoding tool for different Plasmodium spp.  
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This work was limited in sample size, but two large P. vivax genomic studies with new isolates have 
been published subsequently 21,22. In Chapter 7 I gathered the new data together with previously 
analysed and in-house sequenced isolates in order to design a new barcode that could tackle both the 
prediction of geographic origin and the inference of transmission dynamics within the parasite 
populations. The set consisted of >741k SNPs across 446 isolates from 16 countries across the globe. 
Using a neighbour-joining tree method the geographical clustering of the isolates observed in Chapter 
6 was confirmed and it was established that intra-border isolates are closer related based on genomic 
distance than inter-border isolates therefore making a SNP barcode for country classification possible. 
In order to reduce the number of SNPs the analysis was stratified based on partitioning the minor 
allele frequency (MAF) into tertiles. It was found that the SNPs that harbour the highest MAF across 
all the populations drive the geographical clustering observed in the data. The 16,075 pre-selected 
SNPs by MAF > 0.3 were then screened using a SNP tagging software, which identified 1,173 SNPs that 
capture the variability harboured by 40% of the pre-selected SNPs. These SNPs were used to construct 
a random forest model to classify samples according to country of origin. The 60 SNPs with the highest 
classification power were then selected, and complemented by 11 high FST SNPs in order to improve 
classification power. The final set of 71 SNPs were used to train a set comprised of 80% of the isolates, 
accomplishing a 93.4% accuracy in classification by country. Furthermore, the same SNP barcode was 
used to replicate the results of a genomic study in a low-endemic setting in Malaysia 23, and confirmed 
the transmission dynamic trends observed using whole genome sequencing. This work shows that the 
71-SNP barcode outperforms previous results using microsatellites and previously published barcodes 
24. This barcode was constructed, and can be updated, using a straight-forward pipeline and can 
accommodate large sets of isolate data. Ideally, new collections and datasets should be prioritised 
from geographical regions with less sequencing coverage, such as Central America, East Africa and the 
Middle East. One potential study would be the prospective sampling and genotyping using the SNP 
barcode of isolates from malaria endemic regions. By combining mathematical modelling approaches 
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and barcode-informed isolate relatedness, it would be possible to establish the migration patterns of 
the parasite populations across different regions. The reduction in the costs of sequencing and 
genotyping, including of barcode SNPs using PCR-based amplification ($5-10 per sample 25),  will 
facilitate large-scale genomic epidemiological studies. Further extensions of the presented work, 
include the creation of barcodes for other Plasmodium spp., such as P. falciparum for which there is a 
collection of more than 3,000 isolates currently publicly available. These barcodes could be 
complemented with genetic regions that can reveal drug resistance profile of parasites and 
Plasmodium spp. in the same assay. 
 
CONCLUSION 
Whole genome sequencing can be used for the study of Plasmodium parasite populations and its 
genomic diversity. Different sequencing-based technologies can tackle different problems, such as 
long-read platforms for the generation of genome references and resolving complex gene 
morphologies, or short-read sequencing for lower-cost genomic studies of genetic diversity in 
candidate genes. The use of different methodologies such as mapping, de-novo assembly, statistical 
methods, population genetics and phylogenetics, combined with a robust quality control in pre-
analysis steps are the key to enable the correct interpretation of the information harboured by the 
sequencing data.  In this thesis, I have demonstrated the potential of such methodologies to address 
issues such as: (i) the generation of high quality robust new reference genomes for Plasmodium spp., 
(ii) to provide insights into the epigenetics of Plasmodium parasites, (iii) determination of genomic 
dynamics of malaria in complex ecological niches, (iv) inform vaccine deployment and provide insights 
into the potential impact of genetic diversity in vaccine development efforts against malaria, (v) 
determining the genomic population structure within a parasite Plasmodium population, and (vi) the 
generation of genotyping tools for the study of Plasmodium populations and its transmission 
dynamics. 
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THE FUTURE OF PLASMODIUM GENOMIC STUDIES 
It is an exciting time for the study of Plasmodium genomics, with technological improvements in high-
throughput sequencing and genotyping technologies, at lower costs. These innovations make the 
typing of thousands of samples logistically feasible and economically affordable will allow the study 
of large genomic epidemiological studies. The recent WHO 2017 malaria report shows a worrying 
trend regarding funding to fight for malaria elimination, with a large funding gap 26. This fact combined 
with the heterogeneity of malaria transmission 27–29 has forced the key funders and control 
programmes working in the endemic regions to reassess their efforts. This assessment has led to a 
drive to create and deploy tools that can determine foci of infection or hot-spots of transmission, 
thereby assisting the more efficient distribution and application of available resources. 
 
There is still scope for the improvement in the collection of isolates from specific regions of the world, 
to fill in the gaps, such as the Middle East and Africa for P. vivax, and P. falciparum populations in 
Africa. This improvement in geographical resolution would allow for new genomic studies and 
characterization of unknown diversity. Despite this, the tools designed in this thesis could help to 
further understand the dynamics of the parasite populations, especially regarding micro-epidemiology 
within country boundaries. Prospective studies would need to be implemented in order to determine 
the resolution that can be reached in tracking parasite transmission using these tools. These tools 
could also complement those already deployed such as the serological surveillance assays and the use 
of rapid diagnostic tests, both in high transmission and low transmission or near-elimination settings. 
 
The combination of genomic tools together with phenotypic information, such as drug resistance, 
disease severity, vaccine efficacy, or even geographically located data could allow researchers to 
tackle a large number of the still unanswered questions in malaria epidemiology. In the Greater 
Mekong Sub-region (GMS), the WHO has established the target of eliminating artemisinin-resistant 
malaria 30 as the only realistic way to avoid the spread of resistant parasites to other regions of the 
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world. In order to achieve this goal, there is an urgent need for tools that can identify both the drug 
resistant parasites, as well as methods that can predict and survey the dynamics of the parasite 
populations. As shown in Chapter 7, using the relatedness between the parasites to establish 
transmission patterns and events in epidemiological studies is possible. The use of new drug resistance 
molecular markers such as the kelch-13 mutations 31 or the plasmepsin II–III copy number 32 could be 
combined with a P. falciparum barcode, developed in a similar way to the one characterised in Chapter 
7. If implemented in a portable genotyping device, such a barcode could track drug-resistant P. 
falciparum populations across the region, and inform targeted interventions by malaria control 
programmes. 
 
In Chapters 2, 3 and 4, for P. knowlesi I described for the first time in the Plasmodium genera a marked 
mosaicism across highly differentiated subpopulations like the one observed in other parasites such 
as trypanosomes 33. In order to characterize the extent and relevance of such events, further isolate 
collections from different regions are needed, and the phenotypic characterization of the different 
haplotypes presented here need to be established. Prospective longitudinal studies, which would 
track these events across populations, could assist with determining the forces behind such events. 
The sequencing of previously collected samples using the approach described in Chapter 4 could help 
elucidate if such events have played a role in past evolutionary trends, or are effectively a result of 
the current ongoing ecological changes in Malaysia. It is assumed that infections of P. knowlesi are in 
the majority of cases zoonotic events, but these exchanges and introgression events generate an 
immense pool of genetic diversity for the parasite. This diversity combined with the disruption of its 
natural niche, could drive the parasite populations to draw from this genetic pool in order to transition 
to more stable transmission routes, such as human-human infection. 
 
Finally, in Chapter 5 I described the global structural and genetic diversity of the var2csa gene in P. 
falciparum, associated with malaria in pregnancy and a vaccine candidate. For the first time I reported 
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a surprisingly high number of insertions and deletions in the target region ID1-DBL2Xb of the vaccines 
being developed. The impact of such variability should be investigated both from the point of view of 
the disease phenotype (binding to placental CSA receptor) as well as from the point of view of vaccine 
efficacy. Such experiments would need to be approached from a protein modelling point of view, 
given the high abundancy of insertions and deletions found across the isolates. Despite this, using the 
sequences generated in Chapter 5 consensus protein sequences could be created and purified for 
each of the Clades, and their binding affinity studied using more traditional binding affinity assays. 
There is a need to characterize the impact of the parasites with extra copies of the var2csa gene, which 
in this study are shown to be present in all populations; although more prevalent in West Africa. A 
follow-up study could enrol pregnant woman infected with malaria, and collect birth data, any adverse 
outcomes, and a placenta biopsy sample. Parasite material could be obtained from the mothers and 
the placental biopsies, their var2csa sequences compared, and copy number associations with clinical 
phenotype investigated.   
 
The var2csa analysis revealed four “ID1-DBL2Xb” Clades that had uneven distribution across 
geographical regions. The geographic distribution of the clades suggests that there is a need for multi-
clonal vaccine strategies. Further, the appearance of 2 African driven clades needs follow-up 
investigation, particularly to ascertain their prevalence and any association with disease severity 
during pregnancy and adverse outcomes at birth. Furthermore, it is unclear if the association observed 
between some of these clades with adverse outcomes in West Africa can be extrapolated to other 
populations where the 3D7-like clade has been found, such as Southeast Asia. This data could also be 
used to inform geographical locations where the first trials for vaccine deployment should be tested. 
In particular, deployment of a vaccine is expected to be more effective in regions harbouring parasite 
populations with lower diversity. Finally, the methodology described here and the data generated 
could assist the implementation of a baseline survey in regions selected for vaccine trials to compare 
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pre- and post-vaccination deployment parasite populations in order to track selection for clade 
specific variants. 
 
In conclusion, current and emerging technologies have the potential to expand and improve on the 
findings of the work presented in this thesis. The use of sequence-based barcoding of parasites will 
inform on transmission trends, the geographical origin of the isolates, and drug resistance, and 
thereby assist malaria control and elimination efforts. The study of genetic diversity in Plasmodium 
populations can provide insights into their evolutionary and adaptation history, as well as guide the 
development of vaccine design and implementation. More widely, the application of ‘omics 
approaches in epidemiological studies with integration across malaria parasites, vectors and hosts has 
the potential to lead to biological insights to assist the development of new tools for disease control.   
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